Malignant neoplasm of bladder

C3_BLADDER

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Cause of death: ICD-10 — C67 Cause of death: ICD-9 — 188 Cause of death: ICD-8 — 188 Cancer registry: Topography ICD-O-3 — C67 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 2 out of 7 registries used, show all original rules.	3437
4. Check minimum number of events None	3437
5. Include endpoints None	3437
6. Filter based on genotype QC (FinnGen only)	3091

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF9

NAME	C3_BLADDER
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C67
COD_ICD_9	188
COD_ICD_8	188
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C67
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of bladder based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3091	508	2583
Unadjusted period prevalence (%)	1.02	0.18	1.18
Median age at first event (years)	71.48	69.26	71.92

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3198: Matched controls
31952

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A04AA02

ATC

granisetron; systemic, transdermal

671.1

313.3

305

ZX136

NOMESCO Finland

Intravesicalis

173.9

307.7

356

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

307.7

326

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

159.0

307.7

166

H02AB02

ATC

dexamethasone; systemic

44.7

307.7

519

138

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

307.7

625

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

154.9

307.7

162

KCW96

NOMESCO Finland

Other operations on bladder

38.7

307.7

200

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

+∞

307.7

543

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

88.5

307.7

495

A03FA01

ATC

metoclopramide; systemic, rectal

7.5

307.7

886

1545

R31

ICD-10 Finland

Unspecified haematuria

12.5

307.7

1699

2657

KCC10

NOMESCO Finland

Cystoprostatectomy

+∞

307.7

514

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

10983.2

307.7

1687

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

789

Z51.5

ICD-10 Finland

Palliative care

7.3

307.7

572

926

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

4279.0

307.7

389

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

60.5

307.7

199

JN4AD

NOMESCO Finland

Body CT examination

9.2

307.7

742

1019

KCD02

NOMESCO Finland

Transurethral resection of bladder

1489.2

307.7

2377

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

74.4

307.7

322

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

307.7

2456

WF002

NOMESCO Finland

Radical radiotherapy

150.4

307.7

237

C61

ICD-10 Finland

Malignant neoplasm of prostate

715.2

307.7

632

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

307.7

879

UKC02

NOMESCO Finland

Cystoscopy

39.6

307.7

2727

4077

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

130.7

307.7

588

KCB00

NOMESCO Finland

Biopsy of bladder

107.1

307.7

182

TJF80

NOMESCO Finland

Ostomy education

81.0

307.7

205

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

307.7

2114

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

23.3

307.7

375

181

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

6.8

307.7

681

1216

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

250.8

307.7

1291

JN4BD

NOMESCO Finland

Extensive body CT

8.6

307.7

539

738

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

683.1

307.7

889

KCW02

NOMESCO Finland

Lavation of bladder for coagulated blood

17.9

307.7

275

167

A04AA01

ATC

ondansetron; systemic, rectal

15.4

307.7

330

237

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

45.8

307.7

300

KA1AE

NOMESCO Finland

Kidney ultrasound examination

12.8

300.8

302

258

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

109.1

284.3

146

KH1BD

NOMESCO Finland

Extensive urinary tract CT examination

30.9

283.9

187

116

Kela drug reimbursment

Prostate cancer

+∞

283.6

268

J01MA02

ATC

ciprofloxacin; systemic

3.7

279.0

1904

9178

TKW99

NOMESCO Finland

Other minor surgical procedure in urology

37.5

275.2

171

XX3DW

NOMESCO Finland

Time consuming IT work

7.7

266.7

401

584

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

11.9

261.9

275

251

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1347.3

258.7

249

JN4CD

NOMESCO Finland

Very extensive body CT

14.0

252.1

238

183

WC305

NOMESCO Finland

Simple therapy of local tumor recidive with biomodifiers

+∞

251.3

238

U76

ICPC

Malignant neoplasm of bladder

2471.2

251.1

240

WX302

NOMESCO Finland

Thoracal epidural anesthesy

11.5

248.3

266

250

U06

ICPC

Haematuria

8.5

244.2

332

429

KA3EB

NOMESCO Finland

Antegrade pyelography

61.2

242.5

135

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

7.5

235.7

362

538

J01EA01

ATC

trimethoprim; systemic

3.6

233.1

1084

4012

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

80.5

232.6

124

TKC20

NOMESCO Finland

Catheterisation of bladder

4.6

230.0

635

1625

WX408

NOMESCO Finland

General anesthesy, balanced

3.6

226.1

1027

3735

WF049

NOMESCO Finland

Radiotherapy of metastasis

1138.3

220.3

213

1888X

ICD-9 Finland

Malignant neoplasm of bladder, Other specified sites of bladder

+∞

219.3

208

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.6

214.2

929

3265

C67

ICD-10 Finland

Malignant neoplasm of bladder

+∞

211.8

201

B01AB10

ATC

tinzaparin; parenteral

5.1

211.6

494

1098

7321

FHL

TU biopsy, coagulation or laser

46.1

203.6

120

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

199.0

189

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

199.0

189

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

188.4

179

L02AE02

ATC

leuprorelin; implant, parenteral

644.2

186.7

183

WZC00

NOMESCO Finland

Treatment plan or consultation

3.1

180.3

1070

4484

N02AA05

ATC

oxycodone; systemic

3.3

178.8

878

3292

XKD00

NOMESCO Finland

Uroflowmetry

3.1

178.5

1059

4433

UKB02

NOMESCO Finland

Retrograde ureteroscopy

15.5

178.3

157

106

C67.1

ICD-10 Finland

Malignant neoplasm: Dome of bladder

+∞

176.7

168

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

3.3

175.2

843

3118

ZXC20

NOMESCO Finland

Use of chemical agents

13.3

172.5

166

131

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

3.2

171.8

886

3411

C67.4

ICD-10 Finland

Malignant neoplasm: Posterior wall of bladder

+∞

171.4

163

KH1AD

NOMESCO Finland

CT of urinary organs

6.7

165.0

276

446

JN3AD

NOMESCO Finland

Abdominal CT examination

3.7

162.2

603

1885

WF004

NOMESCO Finland

Palliative radiotherapy

1688.3

161.8

156

WX320

NOMESCO Finland

Spinalanesthesy

2.9

160.1

1091

4881

D41.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Renal pelvis

72.7

157.0

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

72.7

157.0

A04AD12

ATC

aprepitant; systemic

+∞

156.5

149

7323

FHL

Electrosection of TU bladder wall change

323.7

152.1

153

B02AA02

ATC

tranexamic acid; systemic

4.2

149.7

451

1213

KA1FN

NOMESCO Finland

Isotope renography

31.9

147.7

8120/3-C67.2

ICD-O-3

Transitional cell carcinoma, NOS, of lateral wall of bladder

+∞

143.8

137

UKA02

NOMESCO Finland

Retrograde ureteronephroscopy

36.6

142.5

A04AA55

ATC

palonosetron, combinations; systemic

+∞

140.6

134

KBJ60

NOMESCO Finland

Anastomosis of ureter to urethra with interposition of ileum

+∞

140.6

134

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

241.9

136.1

139

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

691.3

135.7

133

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

5.8

133.9

255

467

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

6.0

133.6

246

436

WX402

NOMESCO Finland

General anaesthesia

3.1

132.7

654

2416

KC1GB

NOMESCO Finland

Cystography with X-ray

178.7

131.5

137

L02BB03

ATC

bicalutamide; oral

+∞

131.1

125

KCC30

NOMESCO Finland

Cystectomy with excision of female internal genital organs

+∞

131.1

125

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

34.0

130.3

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

45.7

128.7

J01MA12

ATC

levofloxacin; systemic

2.7

128.5

886

3922

WZC30

NOMESCO Finland

Teaching

3.3

124.7

557

1936

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

631.6

124.1

122

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1244.3

123.8

120

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

5.8

123.0

233

424

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

8.7

119.6

154

184

KDV10

NOMESCO Finland

Internal urethrotomy

7.4

119.0

178

254

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

28.1

113.9

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

1126.1

112.2

109

8130/3-C67.9

ICD-O-3

Papillary urothelial carcinoma of bladder, NOS

+∞

111.0

106

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

6.2

111.0

197

336

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

9.6

110.2

131

141

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

108.9

104

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

369.2

107.9

108

TPH07

NOMESCO Finland

Cathetrisation of artery

3.0

106.8

541

2012

JEA00

NOMESCO Finland

Appendectomy

4.7

105.5

257

582

N30.0

ICD-10 Finland

Acute cystitis

2.9

105.0

579

2256

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

104.7

100

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

103.7

NK6AN

NOMESCO Finland

Total body bone isotope imaging

44.4

102.5

L03AA02

ATC

filgrastim; parenteral

125.2

101.6

109

B01AB05

ATC

enoxaparin; parenteral

2.3

101.4

1050

5526

L03AA13

ATC

pegfilgrastim; parenteral

513.4

101.1

100

Y77

ICPC

Malignant neoplasm prostate

210.4

99.0

102

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.9

97.8

535

2070

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

976.7

97.5

C66

ICD-10 Finland

Malignant neoplasm of ureter

+∞

95.2

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

95.2

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.8

92.9

549

2209

SPAT1125

SPAT

Stoma care and guidance

6.9

90.5

142

213

ZXC15

NOMESCO Finland

Use of photodynamic technique

11.2

89.5

1530

FHL

Urethrocystoscopy

5.0

88.8

196

408

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

228.6

86.8

UKD02

NOMESCO Finland

Urethroscopy

16.2

85.6

KCD30

NOMESCO Finland

Destruction of tumour of bladder

223.3

84.8

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

6.1

84.8

151

258

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.8

83.6

194

421

R33

ICD-10 Finland

Retention of urine

2.5

82.9

613

2745

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

818.2

81.8

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

807.7

80.8

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

44.2

80.5

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.1

78.8

371

1312

A06AH03

ATC

naloxegol; oral

14.9

78.5

KH1DD

NOMESCO Finland

CT urography of urinary organs

25.4

78.5

WW500

NOMESCO Finland

Blood transfusion

5.7

78.0

149

272

KBV00

NOMESCO Finland

Insertion of stent into ureter

17.8

77.5

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

77.4

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.5

77.2

577

2589

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

7.2

76.7

115

164

D30.3

ICD-10 Finland

Benign neoplasm: Bladder

33.1

76.2

R82.8

ICD-10 Finland

Abnormal findings on cytological and histological examination of urine

34.8

75.7

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

74.7

1662

11343

G04BE03

ATC

sildenafil; oral

15.9

74.4

U99

ICPC

Urinary disease other

9.6

74.3

C67.5

ICD-10 Finland

Malignant neoplasm: Bladder neck

+∞

73.2

KCC20

NOMESCO Finland

Cystoprostatourethrectomy

+∞

72.1

ZX090

NOMESCO Finland

Other technic of radiotherapy

127.9

70.2

C67.3

ICD-10 Finland

Malignant neoplasm: Anterior wall of bladder

+∞

70.0

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

69.0

WX882

NOMESCO Finland

High dependency care

4.5

68.3

171

394

Z3231

NOMESCO Finland

Registered nurse

2.1

68.2

920

5234

8000/3-C67.9

ICD-O-3

Neoplasm, malignant of bladder, NOS

+∞

66.9

D09.0

ICD-10 Finland

Carcinoma in situ: Bladder

338.8

66.7

WF003

NOMESCO Finland

Adjuvant radiotherapy

338.8

66.7

KCW98

NOMESCO Finland

Other transluminal endoscopic operation on bladder

32.7

65.0

WX224

NOMESCO Finland

Blockade of obturius nerve

328.3

64.7

ZXE00

NOMESCO Finland

One hour or less

1.9

64.4

1166

7321

J01CA08

ATC

pivmecillinam; oral

2.1

64.1

753

4055

1889X

ICD-9 Finland

Malignant neoplasm of bladder, Bladder, part unspecified

+∞

61.6

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

318.7

61.6

PJA12

NOMESCO Finland

Sentinel node biopsy

609.0

60.9

KDV12

NOMESCO Finland

Urethroscopic internal urethrotomy

6.8

60.7

145

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

6.1

60.5

106

178

ZXD10

NOMESCO Finland

Scheduled procedure

1.9

60.2

1172

7499

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

59.3

751

4144

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

13.6

58.8

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

58.2

1089

6863

KAC20

NOMESCO Finland

Nephroureterectomy

+∞

57.4

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

105.3

57.0

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.4

54.2

202

617

N30.9

ICD-10 Finland

Cystitis, unspecified

2.9

53.3

260

932

L01BC06

ATC

capecitabine; oral

+∞

53.3

A79

ICPC

Malignancy NOS

76.5

53.1

N13.1

ICD-10 Finland

Hydronephrosis with ureteral stricture, not elsewhere classified

17.1

53.1

ZXC96

NOMESCO Finland

Robot assisted procedure

15.5

52.8

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

515.7

51.6

U07

ICPC

Urine symptom/complaint other

2.6

51.0

330

1368

4CX01, ,

NOMESCO Finland

+∞

50.1

KBV10

NOMESCO Finland

Removal of stent from ureter

10.7

49.7

J01DB01

ATC

cefalexin; oral

1.8

49.5

2323

18884

KCV22

NOMESCO Finland

Transluminal endoscopic evacuation of blood clots from bladder

20.2

49.5

XKD10

NOMESCO Finland

Transurethral ultrasonography

+∞

49.1

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

132.0

48.9

KCC00

NOMESCO Finland

Cystectomy

484.7

48.5

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

4.4

48.3

122

283

ZX070

NOMESCO Finland

Intensity modified radiotherapy

248.5

48.1

8120/3-C67.4

ICD-O-3

Transitional cell carcinoma, NOS, of posterior wall of bladder

+∞

48.0

8120/2-C67.9

ICD-O-3

Urothelial carcinoma in situ of bladder, NOS

243.4

47.1

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

47.0

115

Kela drug reimbursment

Breast cancer

+∞

47.0

18899

ICD-8 Finland

Malignant neoplasm of bladder

+∞

47.0

N02BE01

ATC

paracetamol; systemic, rectal

1.9

46.4

2579

21827

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

12.7

46.1

KWA00

NOMESCO Finland

Repair of wound dehiscence in urological surgery

+∞

45.9

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

45.9

U28

ICPC

Limited function/disability (U)

5.3

45.7

176

ZZR00

NOMESCO Finland

Flap of skin

9.3

44.8

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.2

44.2

187

617

8120/3-C67.8

ICD-O-3

Transitional cell carcinoma, NOS, of overlapping lesion of bladder

+∞

43.8

C68.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of urinary organs

+∞

43.8

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

43.8

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

43.8

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

5.8

42.5

137

KED22

NOMESCO Finland

Transurethral resection of prostate

2.2

42.4

423

2110

U29

ICPC

Urinary symptom/complaint other

3.5

42.1

150

445

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

55.2

41.5

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.2

41.4

395

1936

GD1AD

NOMESCO Finland

Thorax CT examination

2.7

40.9

231

893

U77

ICPC

Malignant neopl urinary tract other

+∞

40.7

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

402.2

40.2

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

39.6

TKE00

NOMESCO Finland

Needle biopsy of prostate

3.0

39.4

181

626

UKC12

NOMESCO Finland

Retrograde endoscopy of cutaneous cystoenterostomy

+∞

38.6

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

38.6

KBJ80

NOMESCO Finland

Operation for malfunction of urinary diversion

+∞

37.6

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

7.2

37.3

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

371.3

37.1

U70

ICPC

Pyelonephritis/pyelitis

5.2

37.1

148

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.6

36.7

218

864

N02AX02

ATC

tramadol; systemic, rectal

1.6

36.7

1272

9236

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.9

36.4

178

637

JAH00

NOMESCO Finland

Laparotomy

3.7

36.1

117

326

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

186.9

35.8

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

35.5

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

35.5

R50.9

ICD-10 Finland

Fever, unspecified

1.9

35.5

481

2673

SPAT1262

SPAT

Handing over of treatment supplies

1.8

35.4

637

3872

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

5.5

35.3

125

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

4.5

35.0

195

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

96.1

34.8

R4110

NOMESCO Finland

Physiotherapy

1.7

34.6

769

4962

ZX120

NOMESCO Finland

Intravenous

2.4

34.5

264

1177

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

3.1

34.1

144

474

D70.82

ICD-10 Finland

Drug-induced neutropenia

12.8

34.0

N13.9

ICD-10 Finland

Obstructive and reflux uropathy, unspecified

8.7

34.0

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

340.5

34.0

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

8.5

33.5

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

33.4

8120/3-C67.1

ICD-O-3

Transitional cell carcinoma, NOS, of dome of bladder

+∞

33.4

8120/3-C67.6

ICD-O-3

Transitional cell carcinoma, NOS, of ureteric orifice

+∞

33.4

G04BD08

ATC

solifenacin; oral

2.3

33.2

254

1132

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.1

33.2

144

482

Z51.0

ICD-10 Finland

Radiotherapy session

330.2

32.9

Z93.6

ICD-10 Finland

Other artificial openings of urinary tract status

91.0

32.8

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

32.4

313

1535

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

32.3

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

32.3

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

32.3

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

32.3

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

32.3

G04BD12

ATC

mirabegron; oral

1.9

32.0

420

2304

L02AE03

ATC

goserelin; implant

114.4

31.7

N13.0

ICD-10 Finland

Hydronephrosis with ureteropelvic junction obstruction

9.0

31.5

ZXD05

NOMESCO Finland

Urgent procedure

1.6

31.5

951

6617

U13

ICPC

Bladder symptom/complaint other

3.4

31.4

113

337

UKB12

NOMESCO Finland

Retrograde endoscopy of cutaneous ureteroenterostomy

+∞

31.3

8120/3-C67.5

ICD-O-3

Transitional cell carcinoma, NOS, of bladder neck

+∞

31.3

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

31.3

XX2RW, ,

NOMESCO Finland

9.1

31.2

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

70.5

30.9

D41.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Ureter

315.6

30.9

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.8

29.9

159

595

Z93

ICD-10 Finland

Artificial opening status

68.5

29.9

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

4.5

29.9

161

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.5

29.5

101

292

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

4.0

29.3

219

G04CA02

ATC

tamsulosin; oral

1.5

29.3

1364

10439

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

29.2

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

29.2

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

29.2

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

7.3

28.8

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

80.8

28.8

U05

ICPC

Urination problems other

2.3

28.7

239

1103

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

28.2

C67.7

ICD-10 Finland

Malignant neoplasm: Urachus

+∞

28.2

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

+∞

28.2

WX704

NOMESCO Finland

Intubation

2.3

28.0

216

965

KBD00

NOMESCO Finland

Partial excision of ureter

283.7

27.8

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.6

27.7

256

G04BE01

ATC

alprostadil; parenteral, urethral

3.1

27.6

115

376

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.4

27.2

293

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

27.1

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

27.1

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

27.1

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

+∞

27.1

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

6.2

27.0

SPAT1167

SPAT

Insertion of urinary catheter

2.5

27.0

182

765

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

273.1

26.7

J01MA01

ATC

ofloxacin; systemic

2.0

26.7

333

1789

U71

ICPC

Cystitis/urinary infection other

2.7

26.5

146

557

U14

ICPC

Kidney symptom/complaint

3.6

26.4

250

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

26.1

1230

9366

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

26.1

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

26.1

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

26.1

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

26.1

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

262.5

25.7

A02BC02

ATC

pantoprazole; systemic

1.5

25.3

1860

15452

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.2

25.2

226

1074

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

25.0

C67.6

ICD-10 Finland

Malignant neoplasm: Ureteric orifice

+∞

25.0

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

25.0

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

25.0

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.6

25.0

150

597

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.2

24.9

218

1027

Z2221

NOMESCO Finland

Medical doctor

1.6

24.8

677

4557

KAC21

NOMESCO Finland

Percutaneous endoscopic nephroureterectomy

251.9

24.7

KA3GB

NOMESCO Finland

Retrograde pyelography

43.2

24.6

JFF23

NOMESCO Finland

Transversostomy

8.9

24.2

JN6AD

NOMESCO Finland

CT of torso and neck

6.9

24.2

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

4.3

24.1

146

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

56.4

24.0

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

24.0

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

24.0

WC135

NOMESCO Finland

Very demanding cytostatic therapy of local tumor recidive

+∞

24.0

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

24.0

UKC22

NOMESCO Finland

Urethroneocystoscopy

+∞

24.0

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

24.0

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

24.0

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

24.0

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.5

23.9

247

KBH20

NOMESCO Finland

Replantation of ureter

37.8

23.9

C20

ICD-10 Finland

Malignant neoplasm of rectum

241.5

23.7

L57.0

ICD-10 Finland

Actinic keratosis

2.0

23.5

284

1508

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

22.9

L02BB04

ATC

enzalutamide; oral

+∞

22.9

L02BX02

ATC

degarelix; parenteral

+∞

22.9

3AX03, ,

NOMESCO Finland

+∞

22.9

TQW99

NOMESCO Finland

Other minor procedure on skin

2.7

22.8

123

464

J01MA06

ATC

norfloxacin; oral

1.8

22.8

354

2039

KAC10

NOMESCO Finland

Total nephrectomy with capsule

84.0

22.7

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.7

22.6

125

478

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

22.5

1611

13188

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

4.1

22.3

151

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

4.6

21.9

111

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

21.9

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

21.9

C68.0

ICD-10 Finland

Malignant neoplasm: Urethra

+∞

21.9

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

21.9

L02BX03

ATC

abiraterone; oral

+∞

21.9

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

4.4

21.8

128

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

221.3

21.6

U79

ICPC

Neoplasm urinary tract unspecified

115.7

21.6

JFB30

NOMESCO Finland

Right hemicolectomy

6.1

21.5

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

21.5

400

2428

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

21.5

644

4413

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

21.4

338

1955

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

6.3

21.4

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.6

21.2

126

499

KCE02

NOMESCO Finland

Transluminal endoscopic extraction of calculus from bladder

4.0

21.2

152

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.1

21.2

208

1024

L02BG04

ATC

letrozole; oral

34.0

21.1

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

21.0

741

5261

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.6

20.9

195

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

20.8

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

77.3

20.7

KCD10

NOMESCO Finland

Partial cystectomy

77.3

20.7

OAB50, ,

SPAT

1.9

20.6

253

1349

WX702

NOMESCO Finland

Supraglottic ventilation device

2.5

20.6

136

567

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

20.6

246

1301

KH1CB

NOMESCO Finland

Urography with X-ray

25.6

20.4

A03

ICPC

Fever

1.8

20.3

319

1841

TKC22

NOMESCO Finland

Catheterisation instruction

2.8

20.0

104

385

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

19.8

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

19.8

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

19.8

L01CB01

ATC

etoposide; systemic

+∞

19.8

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

19.8

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

19.8

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

19.8

C50.99

ICD-10 Finland

Breast, unspecified

+∞

19.8

KDC00

NOMESCO Finland

Urethrectomy

+∞

19.8

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

19.8

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

19.7

829

6095

J01CA04

ATC

amoxicillin; systemic

1.4

19.6

2077

18035

KH1RT

NOMESCO Finland

Urinary tract dilatatation with radiological guidance

105.6

19.6

N99.5

ICD-10 Finland

Malfunction of external stoma of urinary tract

21.7

19.5

WX002

NOMESCO Finland

Sedation and analgesia

1.6

19.3

516

3433

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.3

19.2

148

661

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.3

19.2

141

617

A41.8

ICD-10 Finland

Other specified sepsis

2.8

19.0

334

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.5

18.9

104

L01CA04

ATC

vinorelbine; systemic

+∞

18.8

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

18.8

8041/3-C67.9

ICD-O-3

Small cell carcinoma, NOS, of bladder, NOS

+∞

18.8

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

18.8

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

18.8

A41.9

ICD-10 Finland

Sepsis, unspecified

2.2

18.8

159

739

KBB00

NOMESCO Finland

Biopsy of ureter

100.6

18.6

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

190.9

18.5

KC1GD

NOMESCO Finland

CT cystography of bladder

38.6

18.5

UJF32

NOMESCO Finland

Coloscopy

1.5

18.5

701

5037

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

3.9

18.5

136

G03HA01

ATC

cyproterone; systemic

30.2

18.3

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

18.2

376

2344

S77

ICPC

Malignant neoplasm of skin

25.2

18.2

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

17.9

221

1180

7343

FHL

Cystectomy and enterocystoplasty

+∞

17.7

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

17.7

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

17.7

G04BE30

ATC

drugs used in erectile dysfunction - combinations

+∞

17.7

L02AE04

ATC

triptorelin; parenteral

+∞

17.7

HAC20

NOMESCO Finland

Total mastectomy

66.9

17.7

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

66.9

17.7

L02BA01

ATC

tamoxifen; oral

36.9

17.6

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

180.8

17.5

KFC10

NOMESCO Finland

Bilateral orchiectomy

180.8

17.5

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

180.8

17.5

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

180.8

17.5

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.0

17.4

194

1000

ZX112

NOMESCO Finland

Subcutaneous

5.1

17.4

N21.0

ICD-10 Finland

Calculus in bladder

3.3

17.3

200

Z93.5

ICD-10 Finland

Cystostomy status

5.8

17.1

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.5

17.0

163

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

16.8

180

915

N30

ICD-10 Finland

Cystitis

2.2

16.8

147

692

N30.8

ICD-10 Finland

Other cystitis

4.8

16.8

HA1AA

NOMESCO Finland

X-ray mammography

3.8

16.8

132

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

63.6

16.7

S18

ICPC

Laceration/cut

1.4

16.7

1201

9667

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

16.7

KCJ10

NOMESCO Finland

Cutaneous cystoenterostomy

+∞

16.7

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

16.7

K62.7

ICD-10 Finland

Radiation proctitis

+∞

16.7

128

Kela drug reimbursment

Cancers of female genital organs

+∞

16.7

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

+∞

16.7

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

16.7

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

16.7

1850A

ICD-9 Finland

Malignant neoplasm of prostate[NEOPLASMA MALIGNUM PROSTATAE]

+∞

16.7

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

35.2

16.7

R4190

NOMESCO Finland

Nutritional therapy

3.3

16.6

190

JFB00

NOMESCO Finland

Partial resection of small intestine

3.7

16.3

144

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

3.4

16.3

168

XJH00

NOMESCO Finland

Transanal ultrasonography

1.8

16.2

263

1531

B01AB04

ATC

dalteparin; parenteral

2.2

16.2

140

656

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

5.3

16.0

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.6

16.0

371

U01

ICPC

Dysuria/painful urination

2.2

16.0

143

679

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

15.9

239

1359

SPAT1168

SPAT

Catheterisation training

4.5

15.8

KWW96

NOMESCO Finland

Other reoperation in urological surgery

60.3

15.8

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

15.6

8120/3-C65.9

ICD-O-3

Transitional cell carcinoma, NOS, of renal pelvis

+∞

15.6

8120/3-C68.9

ICD-O-3

Transitional cell carcinoma, NOS, of urinary system, NOS

+∞

15.6

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

15.6

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

85.4

15.6

2394A

ICD-9 Finland

Neoplasm of unspecified nature, Bladder

85.4

15.6

JAG41

NOMESCO Finland

Repair of stomal hernia, laparoscopic

85.4

15.6

XKW99

NOMESCO Finland

Other physiological examination of urinary or male genital system

3.3

15.3

170

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

15.2

233

D41.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Urinary organ, unspecified

45.2

15.0

TKD00

NOMESCO Finland

Dilatation of urethra

4.2

15.0

WX400

NOMESCO Finland

Inhalation anesthesy

2.7

15.0

301

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

5.0

15.0

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

14.8

549

3908

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

31.8

14.8

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

56.9

14.8

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.2

14.7

125

583

N02AA01

ATC

morphine; systemic, rectal

2.9

14.7

243

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

3.9

14.6

108

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

14.6

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

14.6

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

14.6

Z08.1

ICD-10 Finland

Follow-up examination after radiotherapy for malignant neoplasm

+∞

14.6

C68.9

ICD-10 Finland

Malignant neoplasm: Urinary organ, unspecified

+∞

14.6

C90.0

ICD-10 Finland

Multiple myeloma

+∞

14.6

8140/3-C67.9

ICD-O-3

Adenocarcinoma, NOS, of bladder, NOS

+∞

14.6

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

14.6

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

80.4

14.6

KCH10

NOMESCO Finland

Enterocystoplasty

80.4

14.6

K56.7

ICD-10 Finland

Ileus, unspecified

2.8

14.6

255

V03AE01

ATC

polystyrene sulfonate; oral

2.9

14.6

244

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

11.9

14.5

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

150.5

14.5

D99

ICPC

Disease digestive system other

4.1

14.2

K43.5

ICD-10 Finland

Parastomal hernia without obstruction or gangrene

42.6

14.1

K83.1

ICD-10 Finland

Obstruction of bile duct

4.3

14.1

N45.9

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis without abscess

2.4

13.8

423

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

13.8

462

3216

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

13.7

449

3112

7326

FHL

Bladder lavage

13.6

13.7

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

13.6

193

1079

Z2446

NOMESCO Finland

Social worker

2.0

13.6

147

751

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

13.5

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

13.5

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

13.5

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

13.5

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

13.5

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

13.5

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

13.5

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

13.5

1880A

ICD-9 Finland

Malignant neoplasm of bladder, Trigone of urinary bladder

+∞

13.5

8120/3-C67.0

ICD-O-3

Transitional cell carcinoma, NOS, of trigone of bladder

+∞

13.5

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

13.5

N30.4

ICD-10 Finland

Irradiation cystitis

+∞

13.5

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.3

13.5

101

446

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.3

13.5

148

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

140.5

13.4

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

13.4

362

2403

N02

ICD-10 Finland

Recurrent and persistent haematuria

16.2

13.4

KD1GB

NOMESCO Finland

Uretrocystogpaphy with X-ray

18.3

13.3

SPAT1088

SPAT

Blood transfusion

6.3

13.3

KH1EE

NOMESCO Finland

Urologic ultrasound examination

6.3

13.3

H02AB06

ATC

prednisolone; systemic

1.3

13.2

1297

10836

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.6

13.0

362

2420

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

3.1

13.0

167

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

12.8

150

788

N35.9

ICD-10 Finland

Urethral stricture, unspecified

2.8

12.8

217

U04

ICPC

Incontinence urine

1.8

12.6

186

1053

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

70.1

12.6

4078, ,

NOMESCO Finland

70.1

12.6

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

70.1

12.6

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

70.1

12.6

7339

FHL

Other measure in this category

32.1

12.6

N07BA03

ATC

varenicline; oral

2.5

12.5

330

C76.8

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites

+∞

12.5

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

12.5

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

12.5

8070/3-C67.9

ICD-O-3

Squamous cell carcinoma, NOS, of bladder, NOS

+∞

12.5

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

+∞

12.5

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

+∞

12.5

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

24.4

12.4

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

130.4

12.4

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

3.5

12.3

122

A28

ICPC

Limited function/disability NOS

1.4

12.3

689

5273

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

2.8

12.2

206

U02

ICPC

Urinary frequency/urgency

1.6

12.0

307

2013

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

12.0

748

5823

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

4.7

11.9

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

11.8

423

2980

ZZA00

NOMESCO Finland

Split skin graft

2.4

11.8

315

N05CF01

ATC

zopiclone; oral

1.3

11.8

931

7510

SPAT1255

SPAT

Intravenous administration of medicine

1.7

11.7

198

1167

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

30.1

11.6

JAG43

NOMESCO Finland

Repair of stomal hernia with mesh

65.1

11.6

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

65.1

11.6

C03CA01

ATC

furosemide; systemic

1.3

11.6

1353

11516

WZC15, ,

NOMESCO Finland

19.0

11.6

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.0

11.5

174

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

11.5

385

2675

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.2

11.5

143

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

11.5

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

11.5

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

11.5

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

11.5

1523, ,

Kela drug reimbursment

+∞

11.5

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

11.5

8120/3-C66.9

ICD-O-3

Transitional cell carcinoma, NOS, of ureter

+∞

11.5

8010/3-C67.9

ICD-O-3

Carcinoma, NOS, of bladder, NOS

+∞

11.5

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

11.5

3054, ,

Kela drug reimbursment

+∞

11.5

Z85.5

ICD-10 Finland

Personal history of malignant neoplasm of urinary tract

+∞

11.5

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

11.5

WX892

NOMESCO Finland

Monitored bed care

1.7

11.4

230

1421

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

120.3

11.4

D47.3

ICD-10 Finland

Essential (haemorrhagic) thrombocythaemia

120.3

11.4

T81.9

ICD-10 Finland

Unspecified complication of procedure

3.0

11.3

165

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

1.8

11.3

157

872

M05BX04

ATC

denosumab; parenteral

2.1

11.3

111

549

KCV02

NOMESCO Finland

Cystoscopic balloon distension of bladder

25.1

11.1

HAB40

NOMESCO Finland

Wedge excision of mammary gland

12.7

11.1

Z43.5

ICD-10 Finland

Attention to cystostomy

3.1

11.1

146

JF1AD

NOMESCO Finland

Small bowel CT

4.5

10.9

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

4.7

10.9

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.5

10.9

312

2097

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

11.9

10.8

KFC00

NOMESCO Finland

Unilateral orchiectomy

4.4

10.7

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.6

10.7

227

KC1AE

NOMESCO Finland

Percutaneous ultrasound examination of urinary bladder

5.6

10.7

WX725

NOMESCO Finland

Noninvasive ventilation

1.9

10.7

127

672

N99.1

ICD-10 Finland

Postprocedural urethral stricture

3.7

10.7

A18.1

ICD-10 Finland

Tuberculosis of genitourinary system

60.1

10.6

C50

ICD-10 Finland

Malignant neoplasm of breast

60.1

10.6

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

8.0

10.6

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

10.5

187

1118

KH1AT

NOMESCO Finland

Urinary tract cathetrisation with ultrasound guidance

4.8

10.5

KGH10

NOMESCO Finland

Operation for phimosis

2.0

10.5

107

537

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

3.0

10.4

157

U75

ICPC

Malignant neoplasm of kidney

110.3

10.4

M05BA02

ATC

clodronic acid; systemic

110.3

10.4

KBD22

NOMESCO Finland

Retrograde ureteroscopic destruction of tumour of ureter

110.3

10.4

L02BG03

ATC

anastrozole; oral

110.3

10.4

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

10.4

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

+∞

10.4

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

10.4

KE002

NOMESCO Finland

Radical radiotherapy of prostata and seminal vesicles

+∞

10.4

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

10.4

YX9AW, ,

NOMESCO Finland

+∞

10.4

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

+∞

10.4

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

+∞

10.4

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

10.4

KAD52

NOMESCO Finland

Retrograde ureteronephroscopic destruction of tumour of pelvis of kidney

+∞

10.4

C80

ICD-10 Finland

Malignant neoplasm, without specification of site

+∞

10.4

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

+∞

10.4

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

+∞

10.4

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

+∞

10.4

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

10.4

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

10.4

KDE20

NOMESCO Finland

Removal of foreign body from urethra

4.1

10.4

JDE00

NOMESCO Finland

Gastrojejunostomy

32.6

10.3

R84

ICPC

Malignant neoplasm bronchus/lung

32.6

10.3

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

8.2

10.3

R03BB04

ATC

tiotropium bromide; inhalant

1.4

10.3

412

2965

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

10.3

184

1103

DAB10

NOMESCO Finland

Partial excision of auricle

23.4

10.2

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.7

10.2

192

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

10.2

730

5786

ZXC50

NOMESCO Finland

Cryotherapy

2.5

10.0

247

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.2

10.0

119

KDW98

NOMESCO Finland

Other transluminal endoscopic operations on urethra

40.2

10.0

TQW40

NOMESCO Finland

Remowal of suture of skin

1.8

10.0

136

753

Z3226

NOMESCO Finland

Physiotherapist

1.4

9.9

428

3123

B03XA02

ATC

darbepoetin alfa; parenteral

2.5

9.8

237

8130/1-C67.9

ICD-O-3

Papillary urothelial neoplasm of low malignant potential of bladder, NOS

26.1

9.8

ZX050

NOMESCO Finland

Stereotactic radiotherapy

20.1

9.8

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

10.6

9.8

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

4.7

9.7

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

4.1

9.7

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

9.7

212

1340

N13.8

ICD-10 Finland

Other obstructive and reflux uropathy

13.4

9.7

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

2.7

9.6

187

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

7.8

9.6

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

9.6

396

2865

A06AD11

ATC

lactulose; oral

1.4

9.6

550

4210

E87.5

ICD-10 Finland

Hyperkalaemia

2.1

9.6

392

TKC50

NOMESCO Finland

Training of urinary bladder

9.1

9.5

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.6

9.5

244

1601

WX600

NOMESCO Finland

Single shot through catheter

7.1

9.5

R95

ICPC

Chron obstructive pulmonary disease

1.9

9.5

125

685

SPAT1254

SPAT

Administration of medicine

1.4

9.4

441

3261

C43.99

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin other or unspecified histology

100.2

9.4

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

100.2

9.4

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

100.2

9.4

K43.3

ICD-10 Finland

Parastomal hernia with obstruction, without gangrene

100.2

9.4

KBH96

NOMESCO Finland

Other repair or connection of ureter

100.2

9.4

KB1DG

NOMESCO Finland

Very extensive MRI of urinary tract

100.2

9.4

GDC00

NOMESCO Finland

Lobectomy of lung

17.6

9.4

D75

ICPC

Malignant neoplasm colon/rectum

17.6

9.4

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

9.4

WF090

NOMESCO Finland

Profylactic radiotherapy

+∞

9.4

C34.91

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma

+∞

9.4

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

9.4

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

9.4

198

Kela drug reimbursment

Sorafenib

+∞

9.4

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

9.4

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

+∞

9.4

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

+∞

9.4

WB131

NOMESCO Finland

Very demanding neoadjuvant cytostatic therapy

+∞

9.4

OAA41

NOMESCO Finland

Health check based on individual needs

+∞

9.4

7342

FHL

Cystectomy and differential surgery

+∞

9.4

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

9.4

8070/3-C44.5

ICD-O-3

Squamous cell carcinoma, NOS, of skin of trunk

+∞

9.4

C54.10

ICD-10 Finland

Malignant tumor of endometrium without histology

+∞

9.4

PDQ05

NOMESCO Finland

Insertion of endovascular graft into infrarenal abdominal aorta

2.7

9.4

184

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

9.3

127

703

SPAT1109

SPAT

Analgesia with portable analgesic pump

4.9

9.3

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.1

9.0

421

Z43.6

ICD-10 Finland

Attention to other artificial openings of urinary tract

9.0

WPB10

NOMESCO Finland

Making a convalescent care decision

9.0

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

9.0

138

792

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.9

8.9

116

633

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.9

8.9

107

570

ZQZ00

NOMESCO Finland

Treatment of several skin areas

12.5

8.9

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.7

8.8

300

4199

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.1

8.8

385

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

8.8

476

3605

JFF10

NOMESCO Finland

Loop enterostomy

10.7

8.8

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.7

8.7

162

1544

FHL

Urinary tract endoscopy

14.0

8.7

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

50.1

8.7

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

50.1

8.7

N18.8

ICD-10 Finland

Other chronic renal failure

1.9

8.6

106

568

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

6.6

8.6

RD211, ,

NOMESCO Finland

2.0

8.6

485

TKC00

NOMESCO Finland

Needle biopsy of bladder

16.3

8.5

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

6.9

8.5

PD1AD

NOMESCO Finland

CT of abdominal aorta and branches

3.1

8.5

110

T81.2

ICD-10 Finland

Accidental puncture and laceration during a procedure, not elsewhere classified

3.8

8.5

K52.0

ICD-10 Finland

Gastroenteritis and colitis due to radiation

27.6

8.5

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

90.2

8.4

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

90.2

8.4

KED33

NOMESCO Finland

Transurethral incision of prostate

2.1

8.4

339

L01XX05

ATC

hydroxycarbamide; oral

12.8

8.4

8130/2-C67.2

ICD-O-3

Papillary urothelial carcinoma, non-invasive of lateral wall of bladder

+∞

8.3

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

8.3

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

+∞

8.3

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

8.3

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

8.3

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

8.3

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

8.3

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

8.3

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

8.3

C34.01

ICD-10 Finland

Malignant tumor of the main bronchial epidermoid carcinoma

+∞

8.3

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

8.3

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

+∞

8.3

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

8.3

KBJ00

NOMESCO Finland

Cutaneous ureterostomy

+∞

8.3

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

8.3

G04BE09

ATC

vardenafil; oral

+∞

8.3

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

8.3

8070/3-C44.2

ICD-O-3

Squamous cell carcinoma, NOS, of external ear

+∞

8.3

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

8.3

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

+∞

8.3

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

8.3

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

+∞

8.3

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

+∞

8.3

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

8.3

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

8.3

2113

19417

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.4

8.3

220

SPAT1153

SPAT

Removal of sutures

1.3

8.2

728

5916

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

7.1

8.2

G04AC01, ,

ATC

2.2

8.2

316

WF099

NOMESCO Finland

Other radiotherapy

14.5

8.2

S37.2

ICD-10 Finland

Injury of bladder

33.4

8.1

5997A

ICD-9 Finland

Other disorders of urethra and urinary tract, Haematuria

3.3

8.0

P01AB01

ATC

metronidazole; oral, rectal

1.3

8.0

798

6580

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

2.9

8.0

125

J01XE01

ATC

nitrofurantoin; oral

2.6

7.9

171

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

2.5

7.9

183

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.5

7.9

189

KCH42

NOMESCO Finland

Transurethral incision or resection of bladder neck

4.4

7.9

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

13.0

7.9

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

13.0

7.9

ZXA00

NOMESCO Finland

Right side

1.3

7.9

701

5700

R60.0

ICD-10 Finland

Localized oedema

1.4

7.9

351

2573

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

8.4

7.8

KK1XE

NOMESCO Finland

Other ultrasound examination of retroperitoneal space and genito-urinary tract

10.8

7.8

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

3.8

7.8

KWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in urological surgery

6.9

7.8

WPA13

NOMESCO Finland

Palliative consultation

6.9

7.8

KDD32

NOMESCO Finland

Urethroscopic destruction of tumour of urethra

45.0

7.7

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

45.0

7.7

C43.5

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of trunk

45.0

7.7

KDK10

NOMESCO Finland

Implantation of artificial urinary sphincter around bulbar urethra

45.0

7.7

XX1AD

NOMESCO Finland

Other CT-examination

45.0

7.7

1549

FHL

Other endoscopy

15.0

7.7

N17.8

ICD-10 Finland

Other acute renal failure

2.4

7.7

216

U08

ICPC

Urinary retention

1.9

7.7

526

DHB00

NOMESCO Finland

Excision of lesion of external nose

7.4

7.7

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.4

7.6

223

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

1.8

7.6

114

652

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

25.0

7.6

D41.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Urethra

25.0

7.6

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

3.5

7.5

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

3.3

7.5

A07AA09

ATC

vancomycin; oral

2.4

7.5

194

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

2.8

7.5

130

D41.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other urinary organs

80.2

7.4

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

+∞

7.3

Z08.2

ICD-10 Finland

Follow-up examination after chemotherapy for malignant neoplasm

+∞

7.3

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

7.3

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

7.3

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

7.3

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

+∞

7.3

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

7.3

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

7.3

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

7.3

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

7.3

C43.60

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder without histology

+∞

7.3

KDD30

NOMESCO Finland

Destruction of tumour of urethra

+∞

7.3

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

7.3

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

7.3

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

7.3

C77.4

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes

+∞

7.3

C60.1

ICD-10 Finland

Malignant neoplasm: Glans penis

+∞

7.3

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

7.3

HB000

NOMESCO Finland

Profylactic radiotherapy of mammary gland

+∞

7.3

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

7.3

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

7.3

C60.9

ICD-10 Finland

Malignant neoplasm: Penis, unspecified

+∞

7.3

C43.51

ICD-10 Finland

Malignant melanoma of the trunk originating in lentigo maligna

+∞

7.3

C34.2

ICD-10 Finland

Malignant neoplasm: Middle lobe, bronchus or lung

+∞

7.3

TGD00

NOMESCO Finland

Needle biopsy of lung

10.9

7.3

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

6.8

7.3

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

7.3

376

2824

R30.0

ICD-10 Finland

Dysuria

1.9

7.2

493

KEB00

NOMESCO Finland

Biopsy of prostate

3.0

7.2

100

HAB99

NOMESCO Finland

Other partial excision of mammary gland

7.3

7.2

ZXA05

NOMESCO Finland

Left side

1.3

7.1

645

5248

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

7.9

7.1

KCV04

NOMESCO Finland

Distension of bladder with fluid

3.3

7.1

JG1BG

NOMESCO Finland

MRI of rectum

12.0

7.1

R11

ICD-10 Finland

Nausea and vomiting

1.6

7.1

180

1181

TGE00

NOMESCO Finland

Needle biopsy of mediastinum

8.8

7.0

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

8.8

7.0

Z72.0

ICD-10 Finland

Tobacco use

2.2

7.0

238

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.2

7.0

1031

8876

Z71.8

ICD-10 Finland

Other specified counselling

1.3

6.9

649

5300

JN2AD

NOMESCO Finland

CT examination of lower part of abdomen

6.3

6.9

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

5.8

6.9

SPAT1211

SPAT

Application of soft bandage

1.5

6.9

203

1375

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

13.8

6.9

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

13.8

6.9

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

4.0

6.9

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

4.0

6.9

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

6.9

416

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

1.7

6.8

117

695

E87.2

ICD-10 Finland

Acidosis

3.1

6.8

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

8.3

6.8

JFA70

NOMESCO Finland

Suture of small intestine

6.7

6.8

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

10.9

6.8

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

10.9

6.8

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

2.9

6.8

109

WX610

NOMESCO Finland

Patient controlled analgesia

6.1

6.8

X76

ICPC

Malignant neoplasm breast female

40.1

6.8

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

40.1

6.8

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

2.7

6.7

126

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.4

6.7

173

XKG00

NOMESCO Finland

Artificial induction of erection

16.7

6.7

N30.2

ICD-10 Finland

Other chronic cystitis

3.1

6.7

T83.0

ICD-10 Finland

Mechanical complication of urinary (indwelling) catheter

3.9

6.7

C44.3

ICD-10 Finland

Malignant neoplasm: Skin of other and unspecified parts of face

22.5

6.7

G04CA01

ATC

alfuzosin; oral

1.3

6.7

548

4402

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

2.3

6.6

199

Z00.0

ICD-10 Finland

General medical examination

1.3

6.6

472

3721

D40.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Testis

3.5

6.5

S10

ICPC

Boil/carbuncle

1.7

6.5

127

781

JMA10

NOMESCO Finland

Transabdominal total splenectomy

8.7

6.5

KAD00

NOMESCO Finland

Partial nephrectomy

8.7

6.5

JAH01

NOMESCO Finland

Laparoscopy

2.2

6.5

252

KGB00

NOMESCO Finland

Biopsy of penis

6.8

6.5

H01CB03

ATC

lanreotide; parenteral

69.9

6.4

C44.40

ICD-10 Finland

Malignant tumor of the skin of the scalp and neck without histology

69.9

6.4

C44.20

ICD-10 Finland

Malignant tumor of the skin of the outer ear and of the outer ear canal without histology

69.9

6.4

22330

ICD-8 Finland

Benign neoplasm of kidney and other urinary organs, Bladder

69.9

6.4

SPAT1263

SPAT

Sampling

1.2

6.4

983

8481

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.2

6.4

241

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

6.3

129

803

R39.1

ICD-10 Finland

Other difficulties with micturition

1.7

6.3

103

604

SPAT1172

SPAT

Guidance concerning hydration

1.8

6.3

472

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

1.7

6.3

568

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

11.0

6.3

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

6.3

509

4078

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

2.6

6.3

131

J01DA01

ATC

[U] cefalexin

1.2

6.3

1594

14440

N32.0

ICD-10 Finland

Bladder-neck obstruction

2.4

6.3

173

KB1CG

NOMESCO Finland

Extensive MRI examination of urinary tract with high intensity magnet

18.0

6.3

JA3CT

NOMESCO Finland

Cathetrisation of abdominal cavity with CT guidance

18.0

6.3

GD2CT

NOMESCO Finland

Cytology of the lungs with CT guidance

18.0

6.3

PJD53

NOMESCO Finland

Block dissection of aortic lymph nodes

+∞

6.2

C80.0

ICD-10 Finland

Malignant neoplasm, primary site unknown, so stated

+∞

6.2

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

6.2

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

6.2

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

6.2

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

6.2

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

6.2

9680/3-C67.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of bladder, NOS

+∞

6.2

C57.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of female genital organs

+∞

6.2

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

+∞

6.2

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

6.2

C34.81

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma

+∞

6.2

C34.15

ICD-10 Finland

Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma

+∞

6.2

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

6.2

8140/3-C67.7

ICD-O-3

Adenocarcinoma, NOS, of urachus

+∞

6.2

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

+∞

6.2

9061/3-C62.9

ICD-O-3

Seminoma, NOS, of testis, NOS

+∞

6.2

8140/3-C80.9

ICD-O-3

Adenocarcinoma, NOS, of unknown primary site

+∞

6.2

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

6.2

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

6.2

KBC00

NOMESCO Finland

Ureterectomy

+∞

6.2

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

6.2

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

6.2

1820A

ICD-9 Finland

Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[CARCINOMA ENDOMETRII]

+∞

6.2

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

6.2

8070/3-C32.9

ICD-O-3

Squamous cell carcinoma, NOS, of larynx, NOS

+∞

6.2

C34.0

ICD-10 Finland

Malignant neoplasm: Main bronchus

+∞

6.2

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

6.2

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

6.2

XW000

NOMESCO Finland

Bone marrow biopsy

1.9

6.2

359

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

26.7

6.2

JFC20

NOMESCO Finland

Other enterocolostomy

26.7

6.2

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

2.2

6.2

218

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

0.2

6.2

334

UJG02

NOMESCO Finland

Proctoscopy

2.2

6.2

212

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

6.1

1499

13520

WPA44, ,

SPAT

5.7

6.1

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

3.2

6.1

G04BD11

ATC

fesoterodine; oral

1.9

6.1

405

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

4.1

6.1

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

12.5

6.1

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.1

6.1

273

K65.0

ICD-10 Finland

Acute peritonitis

2.4

6.0

164

KCH00

NOMESCO Finland

Suture of bladder

10.0

6.0

D40.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Male genital organ, unspecified

10.0

6.0

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.8

6.0

479

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3049717) Cytology report of Urine Cyto stain

1597

1052

29.30

307.65

6.1

1.8

—

(3002256) Pathology report gross observation

1034

1570

9.25

307.65

1.8

1.1

—

(3026008) Bacteria identified in Urine by Culture

1855

7249

4.71

307.65

6.8

3.3

—

(4035726) Immunohistochemistry procedure

551

534

12.25

307.65

1.4

1.2

—

(40768804) Tissue Pathology biopsy report

1525

5837

4.08

307.65

3.3

1.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1780

9777

2.85

180.96

4.2

2.5

—

estimate

—

(3044640) Blood type and Crossmatch panel - Blood

1403

6867

2.86

177.00

3.6

2.3

—

(3002582) Erythrocytes [#/volume] in Urine

1577

8283

2.78

172.39

10.7

3.3

307.14

108.92

e6/l

2.32

1376

6477

(3000850) Epithelial cells [#/volume] in Urine

1233

5870

2.79

160.75

6.1

2.6

5.09

3.69

e6/l

3.34

1177

5307

(3018095) Leukocytes [#/volume] in Urine

1617

8983

2.62

152.33

11.7

3.9

326.74

134.08

e6/l

3.01

1392

6587

(36304419) Bacteria [Presence] in Urine

1301

6510

2.68

151.88

10.6

3.2

34.06

0.00

estimate

0.69

(3030467) Casts [#/volume] in Urine by Automated count

1364

6998

2.65

151.18

10.6

3.2

0.46

0.51

e6/l

0.45

1189

5269

(3031040) Bacteria [#/volume] in Urine by Automated count

2289

15140

2.80

149.10

13.9

4.7

301.19

1905.98

e6/l

2.71

320

(3023368) Bacteria identified in Blood by Culture

1488

8089

2.57

144.58

5.9

4.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

913

3937

2.84

140.96

10.7

3.1

1.16

1.55

e6/l

1.69

664

2067

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

951

4300

2.72

132.87

10.1

3.0

2.17

1.19

e6/l

5.69

697

2437

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1076

5205

2.61

130.80

3.5

2.2

—

(3026782) Osmolality of Urine

1037

4960

2.61

128.68

6.8

2.9

547.08

549.20

mosm/kgh2o

0.14

975

4320

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

439

1308

3.73

125.07

3.4

1.4

43.80

24.60

ug/l

0.24

375

985

(3012095) Magnesium [Moles/volume] in Serum or Plasma

842

3723

2.71

121.52

5.0

2.4

0.79

0.82

mmol/l

10.37

802

3413

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1822

11526

2.35

118.34

9.2

3.9

10.90

13.32

umol/l

10.07

1771

10829

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

497

1773

3.13

105.41

5.1

3.6

0.38

1.97

mmol/l

13.55

370

1251

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

539

2054

2.95

101.52

5.8

3.8

4.98

5.17

kpa

6.28

523

1938

(3009343) pH of Capillary blood

528

1998

2.96

100.67

5.7

3.8

7.41

3.50

479

1679

(3000991) Gas panel - Venous blood

590

2417

2.76

96.72

11.3

7.8

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1652

10604

2.15

96.07

6.2

4.0

32.84

34.61

g/l

24.19

1569

9736

(3013650) Neutrophils [#/volume] in Blood by Automated count

1754

11693

2.10

90.26

12.0

5.7

4.95

4.63

e9/l

3.30

1541

9892

(3021447) Carbon dioxide [Partial pressure] in Venous blood

685

3189

2.46

85.37

5.2

3.6

5.90

5.84

kpa

0.80

674

3087

(3002032) Base excess in Venous blood by calculation

673

3116

2.47

84.83

5.2

3.6

1.29

1.79

mmol/l

2.81

603

2664

(3012544) pH of Venous blood

686

3226

2.43

83.42

5.3

3.7

7.36

7.38

6.59

441

1936

(3022313) Gas panel - Capillary blood

396

1410

3.06

83.30

6.0

4.0

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

707

3392

2.39

82.06

6.2

5.7

1.04

mmol/l

0.09

673

3093

(3014111) Lactate [Moles/volume] in Serum or Plasma

581

2563

2.55

80.90

9.3

6.6

1.39

1.46

mmol/l

0.43

569

2493

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

327

1061

3.32

80.33

5.8

4.3

23.83

24.76

mmol/l

6.27

310

954

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

469

1873

2.76

79.74

2.5

1.9

0.21

0.19

g/l

4.20

438

1685

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

595

2754

2.42

74.14

4.1

2.0

230.34

237.50

u/l

0.61

570

2530

(3020779) Urea [Moles/volume] in Serum or Plasma

581

2671

2.43

73.44

6.1

6.6

12.48

12.41

mmol/l

0.07

552

2507

(3015235) Bicarbonate [Moles/volume] in Capillary blood

330

1148

3.09

71.89

3.7

3.0

23.13

24.71

mmol/l

10.18

330

1128

(3030981) Hyaline casts [#/volume] in Urine by Automated count

528

2364

2.48

70.50

5.4

2.4

0.79

0.49

e6/l

1.32

520

2273

(42870588) Differential panel, method unspecified - Blood

1184

7311

1.98

70.07

6.2

5.1

—

(3009261) Glucose [Presence] in Urine by Test strip

1728

12163

1.91

68.54

6.9

3.9

2.63

0.02

estimate

0.50

384

2292

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1614

11114

1.91

68.44

9.1

6.0

1.20

mmol/l

2.64

1516

10020

(3015736) pH of Urine

1452

9664

1.92

68.27

6.0

3.5

6.29

6.26

0.47

829

5215

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1751

12394

1.91

68.09

9.5

6.4

1.20

mmol/l

3.88

1524

10552

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

419

1707

2.67

67.93

11.2

8.2

23.38

24.25

mmol/l

6.33

405

1636

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

435

1807

2.63

67.81

11.4

8.6

0.50

0.64

12.12

427

1790

(3032080) INR in Blood by Coagulation assay

1801

12887

1.91

67.50

19.4

22.6

1.32

1.45

inr

18.05

1548

10977

(3035350) Ketones [Presence] in Urine by Test strip

1718

12111

1.90

67.38

6.9

3.9

6.28

2.56

estimate

0.38

407

2523

(3013826) Glucose [Moles/volume] in Serum or Plasma

1961

14438

1.92

67.22

8.0

5.0

7.05

7.02

mmol/l

0.29

1908

13758

(3021601) Nitrite [Presence] in Urine by Test strip

1698

11934

1.90

67.12

6.8

3.9

0.00

estimate

0.50

386

2469

(3027801) Oxygen [Partial pressure] in Arterial blood

688

3532

2.21

66.49

9.3

6.7

13.13

11.14

kpa

19.93

658

3373

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

688

3533

2.20

66.44

9.3

6.7

5.08

5.03

kpa

0.60

663

3378

(3003396) Base excess in Arterial blood by calculation

683

3509

2.20

65.81

9.2

6.7

-0.29

1.06

mmol/l

12.42

579

2812

(3019977) pH of Arterial blood

682

3502

2.20

65.80

9.3

6.8

7.40

7.42

4.22

310

2051

(3002173) Hemoglobin [Mass/volume] in Arterial blood

585

2820

2.31

65.77

10.2

7.5

114.91

121.94

g/l

15.61

579

2768

(3016502) Oxygen saturation in Arterial blood

635

3174

2.25

65.44

9.6

6.9

96.09

94.61

7.68

618

3058

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

441

1877

2.56

65.26

11.2

8.3

1.10

1.34

6.90

433

1859

(3019069) Monocytes/Leukocytes in Blood

1465

10046

1.84

60.35

6.7

5.4

9.31

9.33

0.08

1393

9234

(3006504) Eosinophils/Leukocytes in Blood

1461

10029

1.84

59.82

6.6

5.3

2.71

2.98

4.33

1394

9223

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

375

1547

2.61

58.90

10.9

9.6

15.39

16.00

4.80

369

1500

(3002030) Lymphocytes/Leukocytes in Blood

1472

10164

1.83

58.80

6.7

5.4

22.82

24.76

9.01

1415

9485

(3022096) Basophils/Leukocytes in Blood

1454

10051

1.82

57.44

6.7

5.4

0.59

0.62

1.31

1386

9249

(3015377) Calcium [Moles/volume] in Serum or Plasma

1157

7464

1.86

57.19

4.9

2.1

2.33

2.34

mmol/l

0.44

1046

6498

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2159

16854

1.86

56.58

11.9

5.7

89.93

78.72

u/l

8.96

2089

15643

(3018010) Neutrophils/Leukocytes in Blood

1434

9991

1.79

54.16

6.6

5.3

61.26

59.66

5.04

1380

9407

(3013115) Eosinophils [#/volume] in Blood

1562

11297

1.75

50.64

6.5

5.2

0.20

0.21

e9/l

2.65

1321

9632

(3006315) Basophils [#/volume] in Blood

1527

10996

1.74

50.09

6.3

5.1

0.04

e9/l

0.04

1281

9262

(3001604) Monocytes [#/volume] in Blood

1519

10928

1.74

49.95

6.3

5.1

0.68

0.65

e9/l

4.73

1277

9189

(3019198) Lymphocytes [#/volume] in Blood

1543

11163

1.74

49.62

6.5

5.2

1.78

1.75

e9/l

0.17

1322

9611

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

105

7.18

49.54

1.4

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

156

438

3.69

47.55

2.6

1.7

714.83

363.42

u/ml

0.29

139

349

(3033658) Prothrombin time (PT) actual/Normal

869

5382

1.84

47.17

6.0

3.8

83.95

78.52

8.64

860

5260

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

392

1831

2.30

46.42

1.7

1.6

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1096

7327

1.75

45.67

3.8

2.4

117.33

61.71

u/l

0.55

1047

6744

(3045414) Leukocytes [Presence] in Urine

450

2269

2.14

44.00

3.5

1.9

0.05

0.01

estimate

0.62

441

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

251

978

2.70

43.82

2.7

0.34

iu/ml

0.00

117

563

(3035637) Corticotropin [Mass/volume] in Plasma

155

5.53

43.43

1.3

1.5

24.57

22.40

ng/l

0.38

155

(3003129) Base excess in Capillary blood by calculation

133

364

3.77

42.06

2.6

2.3

-1.48

0.10

mmol/l

3.55

123

347

(3014051) Protein [Presence] in Urine by Test strip

893

5753

1.76

41.60

5.1

3.1

0.32

0.05

1.29

222

(3028626) Oxygen [Partial pressure] in Capillary blood

209

764

2.85

41.18

3.8

3.0

8.37

7.69

kpa

7.41

209

745

(3042936) Bacteria identified in Isolate by Culture

597

3538

1.84

36.13

2.2

2.1

—

(1616796) Gas panel - Central venous blood

178

640

2.88

36.12

4.1

3.9

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

8.70

33.99

1.3

1.1

—

(3003694) ABO and Rh group [Type] in Blood

797

5223

1.70

33.76

1.4

1.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

648

4022

1.76

33.32

3.0

2.8

20.15

22.08

3.42

610

3678

(3018677) aPTT in Platelet poor plasma by Coagulation assay

655

4097

1.75

32.71

2.4

1.8

29.73

30.19

1.43

642

3984

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

268

1243

2.26

31.87

1.9

1.7

2.48

1.92

ug/l

0.42

235

1071

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

115

344

3.43

31.84

5.4

6.0

12.85

12.45

mg/l

0.41

108

312

(3004789) Transferrin [Mass/volume] in Serum or Plasma

682

4349

1.72

31.67

2.9

2.7

2.18

2.21

g/l

0.72

635

3942

(3022948) Iron [Moles/volume] in Serum or Plasma

719

4654

1.70

31.60

3.0

2.7

10.97

12.12

umol/l

4.50

680

4256

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

203

4.17

30.69

1.1

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

761

5071

1.66

29.69

2.1

1.9

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

310

1569

2.08

29.50

1.6

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

993

7086

1.58

29.13

7.1

4.0

0.01

0.00

estimate

0.55

300

2150

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1001

7158

1.58

29.09

2.5

2.4

2.99

2.87

mg/l

0.78

882

6059

(3045424) Erythrocytes [Presence] in Urine

244

1134

2.24

28.83

3.1

1.9

0.17

0.79

estimate

0.36

318

(3024354) Oxygen [Partial pressure] in Venous blood

460

2689

1.83

28.56

3.7

3.0

4.20

4.39

kpa

1.46

448

2589

(3036481) Cortisol [Moles/volume] in Serum or Plasma

329

1730

2.00

28.14

4.8

1.8

417.69

373.76

nmol/l

2.99

314

1555

(3004809) Band form neutrophils/Leukocytes in Blood

100

297

3.44

28.02

2.4

2.3

1.84

1.50

0.22

248

(3011397) Hemoglobin [Presence] in Urine by Test strip

828

5713

1.60

27.78

6.6

3.8

0.33

0.17

—

(3041096) Erythrocytes [Presence] in Urine by Automated

855

5950

1.59

27.65

5.9

3.5

1.40

0.03

estimate

0.73

247

1866

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1203

9055

1.52

27.34

7.3

4.0

3.76

0.03

estimate

0.81

271

2002

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

341

1868

1.92

25.82

2.6

2.2

42.39

39.71

u/l

0.24

283

1505

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

336

1840

1.92

25.45

1.9

1.7

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

356

1993

1.88

25.20

4.5

3.3

123.67

129.22

g/l

4.32

347

1935

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2399

21060

1.55

24.60

32.8

18.1

39.75

28.83

mg/l

37.25

2261

17846

(40768800) Prostate Pathology biopsy report

188

3.89

24.41

1.2

1.1

—

(3019225) pH of Specimen

409

2421

1.79

24.13

5.3

3.8

7.35

7.36

0.19

339

1616

(3027273) Bicarbonate [Moles/volume] in Venous blood

294

1583

1.94

23.37

5.1

3.3

24.47

25.04

mmol/l

1.71

288

1521

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

204

981

2.15

22.09

3.1

2.9

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

898

6582

1.50

22.08

3.7

2.6

34.07

38.64

u/l

0.77

857

6124

(3022621) pH of Urine by Test strip

321

1812

1.86

22.04

4.3

2.8

6.08

6.02

0.49

245

1321

(3018418) pH of Serum or Plasma

952

7105

1.48

21.26

4.9

3.5

7.39

7.40

2.40

729

5138

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

678

4733

1.55

20.75

3.8

2.2

2.49

2.45

mmol/l

12.88

604

4124

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1206

9527

1.43

19.53

3.4

3.1

174.78

156.61

ug/l

1.32

1120

8649

(3021589) Normoblasts [#/volume] in Blood

1175

9280

1.42

18.88

16.5

11.0

0.00

e9/l

0.98

930

7482

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

373

2303

1.70

18.74

2.8

2.1

10.30

9.27

umol/l

0.27

325

2019

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

272

3.03

18.65

2.6

1.7

118.24

36.60

u/ml

1.05

250

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

217

1149

1.95

18.06

2.3

1.8

—

(3000330) Specific gravity of Urine by Test strip

250

1391

1.86

17.90

6.6

3.5

1.02

ratio

5.46

232

1278

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

201

1061

1.95

16.88

2.2

1.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

204

3.23

16.79

3.1

2.6

—

(3017354) Segmented neutrophils/Leukocytes in Blood

211

3.17

16.55

2.3

2.4

65.55

61.31

0.91

174

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

264

2.88

15.93

1.2

1.1

—

(40758558) Short blood count panel - Blood

819

6221

1.42

15.80

9.2

4.7

—

(40767503) Oxygen content in Capillary blood by calculation

127

581

2.23

15.61

3.1

2.6

16.11

16.47

0.59

127

568

(3017181) Myelocytes/Leukocytes in Blood

305

1878

1.69

15.39

3.8

3.4

0.95

0.74

0.80

129

444

(40761511) CBC panel - Blood by Automated count

2347

21182

1.40

15.31

29.5

16.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

542

3840

1.49

14.97

1.9

1.8

—

(3021440) Promyelocytes/Leukocytes in Blood

295

1823

1.68

14.68

3.8

3.5

0.11

0.07

0.63

123

393

(3002179) Metamyelocytes/Leukocytes in Blood

289

1779

1.68

14.59

3.6

3.3

0.62

0.57

0.16

128

428

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2217

19890

1.37

14.47

34.8

17.7

65.50

70.47

ml/min/173m2

24.77

2149

18501

(3019060) Gas panel - Arterial blood

307

1941

1.64

13.97

5.1

4.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1420

11970

1.33

13.82

2.6

2.3

92.23

91.73

pmol/l

0.15

924

6667

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

243

1448

1.73

13.81

1.6

1.5

1.80

1.51

g/l

4.26

214

1232

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

294

1844

1.65

13.80

4.4

2.6

58.32

59.17

ml/min/173m2

0.15

155

760

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

242

2.80

13.62

2.6

2.0

2.36

1.30

u/field

0.68

139

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

115

535

2.19

13.60

1.8

1.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2429

22201

1.39

13.52

41.1

23.2

139.19

139.75

mmol/l

20.66

2395

21661

(3023103) Potassium [Moles/volume] in Serum or Plasma

2430

22227

1.38

13.35

41.3

23.3

4.08

4.04

mmol/l

11.25

2396

21654

(3009214) Lutropin [Units/volume] in Serum or Plasma

327

2.51

13.23

1.2

1.3

15.28

7.40

u/l

5.25

254

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

249

1512

1.70

13.21

1.6

1.5

—

(3037121) Protein [Mass/volume] in Urine

159

845

1.93

13.12

2.8

2.5

2035.40

325.46

mg/l

0.52

325

(3023323) Follitropin [Units/volume] in Serum or Plasma

108

3.73

13.05

1.2

1.3

35.93

24.33

iu/l

1.06

(40768441) Liver Pathology biopsy report

5.46

13.04

1.4

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

412

2834

1.52

13.00

2.0

1.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

499

3573

1.47

12.93

2.0

1.9

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

251

2.70

12.73

3.1

3.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

134

3.39

12.71

2.5

1.8

15.87

1.84

u/field

0.72

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

106

3.71

12.62

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

106

3.71

12.62

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

100

454

2.24

12.58

1.9

83.55

87.39

0.96

100

441

(3006184) Hemoglobin [Mass/volume] in Capillary blood

140

725

1.97

12.47

2.3

2.2

127.19

131.07

g/l

0.99

112

575

(40768795) Lymph node Pathology biopsy report

6.21

12.45

1.3

1.1

—

(3024928) Oxygen saturation in Venous blood

140

729

1.96

12.28

2.9

59.58

59.15

0.08

135

684

(4024509) Urine culture

198

1157

1.76

12.06

2.7

1.9

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2440

22462

1.36

11.89

45.1

24.3

103.05

91.22

umol/l

19.34

2411

22036

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

115

565

2.07

11.86

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

706

5461

1.37

11.72

4.7

232.90

541.13

ng/l

2.87

627

4895

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

5.13

11.71

5.6

1.0

15.20

37.12

u/ml

—

(3007461) Platelets [#/volume] in Blood

2443

22525

1.35

11.55

48.3

26.7

243.01

228.20

e9/l

19.05

2388

21838

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2443

22525

1.35

11.55

48.1

26.6

92.03

92.10

0.27

2410

22088

(3035941) MCH [Entitic mass]

2443

22525

1.35

11.55

48.1

26.6

30.31

30.64

14.84

2408

22090

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2443

22525

1.35

11.55

49.6

27.2

37.68

40.06

67.07

2402

22079

(3026361) Erythrocytes [#/volume] in Blood

2443

22526

1.35

11.54

48.2

26.7

4.21

4.43

e12/l

68.32

2376

21723

(3000963) Hemoglobin [Mass/volume] in Blood

2443

22527

1.35

11.53

48.6

26.9

125.12

134.82

g/l

128.86

2405

22102

(3010813) Leukocytes [#/volume] in Blood

2443

22530

1.35

11.50

48.3

26.7

7.73

7.03

e9/l

26.41

2379

21734

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1634

14271

1.29

11.43

5.5

4.5

2.71

2.29

ug/l

1.87

1395

12732

(3023520) Reticulocytes [#/volume] in Blood

399

2800

1.48

11.37

2.6

2.0

71.84

66.01

e9/l

0.68

298

2132

(3025159) Blasts/Leukocytes in Blood

281

1832

1.58

11.24

3.9

3.6

0.06

0.01

0.84

109

355

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

256

2.57

11.23

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

256

2.57

11.23

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

257

2.56

11.14

1.3

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1825

16203

1.29

11.10

4.6

4.4

18.73

13.64

mm/h

22.30

1693

14886

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

8.04

11.05

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

267

2.50

10.80

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

161

2.95

10.59

1.2

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

271

2.46

10.48

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

265

2.48

10.48

1.3

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

345

2391

1.50

10.43

2.2

1.6

65.34

66.17

g/l

1.16

315

2115

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1175

9916

1.29

10.39

3.3

3.5

2388.53

2079.23

ng/l

0.94

1050

8695

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2369

21855

1.32

10.37

15.9

10.9

24.52

25.39

u/l

1.11

2298

20854

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1436

12447

1.28

10.21

3.8

3.2

65.56

55.13

u/l

2.32

1330

11284

(3022145) Colonoscopy Study observation

303

2055

1.52

10.16

1.4

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

165

2.87

10.15

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

10.04

9.99

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

147

834

1.80

9.94

1.4

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

153

880

1.77

9.88

1.3

1.2

—

(3012501) Base excess in Blood by calculation

109

564

1.96

9.80

4.8

4.6

2.30

2.73

mmol/l

0.75

370

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1129

9535

1.28

9.77

2.5

2.3

—

(40761536) Microorganisms panel - Urine sediment

248

1640

1.55

9.33

6.9

4.0

—

(3027945) Reticulocytes/Erythrocytes in Blood

484

3645

1.38

9.28

2.6

1.9

1.82

1.74

0.93

429

3154

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

112

600

1.90

9.11

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

250

2.38

8.81

1.3

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

132

761

1.76

8.50

7.7

4.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1245

10791

1.25

8.29

5.2

4.6

50.38

97.53

ng/l

1.94

1072

8769

(3007930) Methemoglobin/Hemoglobin.total in Blood

199

1294

1.57

8.08

6.1

4.9

0.85

0.86

0.05

194

1235

(3008152) Bicarbonate [Moles/volume] in Arterial blood

287

2025

1.46

7.92

8.0

6.5

23.57

24.31

mmol/l

1.91

276

1954

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

213

1415

1.54

7.87

5.7

4.7

1.61

0.01

208

1352

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

273

1910

1.47

7.87

4.3

4.1

106.89

107.27

ng/l

0.02

236

1601

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

688

8343

0.78

7.80

1.9

2.0

1.42

1.27

mmol/l

2.74

575

6800

(40768443) Skin Pathology biopsy report

141

851

1.69

7.74

1.3

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

108

606

1.81

7.65

2.6

2.5

1.97

1.91

mg/l

0.24

511

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

176

1132

1.59

7.51

2.4

2.1

706.02

771.96

ug/l

0.09

170

1078

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

356

2651

1.38

7.25

5.4

3.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

209

1416

1.51

7.07

1.7

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

341

2.01

6.79

2.3

2.2

25.13

20.09

mg/l

0.29

119

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

3.03

6.75

2.3

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

316

2.04

6.67

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

3.40

6.40

1.6

2.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

441

1.86

6.38

1.5

30.58

26.94

g/l

2.05

387

(46235355) HIV 1 and 2 tests - Meaningful Use set

249

1783

1.43

6.37

1.6

1.5

—

(40768806) Pleura Pathology biopsy report

288

2.07

6.36

1.6

1.5

—

(3047181) Lactate [Moles/volume] in Blood

135

850

1.61

6.34

6.1

5.8

1.37

1.39

mmol/l

0.06

118

761

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

264

1912

1.41

6.34

4.7

3.2

1.22

mmol/l

0.93

243

1600

(3011648) Oxygen content in Venous blood

264

2.10

6.20

1.5

1.8

9.89

9.85

0.02

264

(3012441) Differential panel - Pleural fluid

312

2.00

6.17

1.3

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

335

1.96

6.05

1.2

1.5

23408.39

73642.34

e6/l

1.16

199

(3017732) Neutrophils [#/volume] in Blood

336

2557

1.35

5.97

3.3

2.8

4.96

4.89

e9/l

0.11

269

2090

(3026493) Urate [Moles/volume] in Serum or Plasma

777

6590

1.24

5.89

3.1

2.8

391.23

377.20

umol/l

3.05

677

5558

(3023199) Leukocytes [#/volume] in Pleural fluid

381

1.88

5.88

1.3

1.5

1239.35

1922.55

e6/l

0.54

281

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

118

733

1.63

5.88

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

510

4131

1.28

5.76

5.1

4.0

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1787

16438

1.20

5.72

40.3

21.7

14.37

13.86

38.28

1764

16129

(3019150) Specific gravity of Urine by Refractometry

681

5729

1.24

5.53

8.4

4.2

1.02

kg/l

0.66

563

3793

(3042631) Mycobacterium sp identified in Specimen

355

1.88

5.45

3.1

2.9

—

(3043410) Blood group antigens tested for on Red Blood Cells

3.15

5.45

1.8

1.6

—

(3018572) Chloride [Moles/volume] in Blood

562

1.69

5.45

7.5

6.8

105.60

105.00

mmol/l

0.71

515

(3039000) Anion gap in Blood by calculation

562

1.69

5.45

7.4

6.8

11.35

11.53

mmol/l

0.18

515

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

137

903

1.54

5.34

2.2

1.5

2.35

1.69

ratio

0.66

528

(3034860) Kappa light chains.free [Mass/volume] in Serum

150

1011

1.51

5.28

2.2

1.5

73.49

53.68

mg/l

1.14

125

846

(3005719) IgG [Mass/volume] in Serum or Plasma

187

1325

1.44

5.11

2.3

2.1

10.54

10.96

g/l

0.70

174

1212

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

149

1010

1.50

5.11

2.2

1.5

44.59

37.98

mg/l

0.66

124

842

(43055442) Apixaban [Mass/volume] in Serum or Plasma

3.01

5.09

1.5

1.8

80.44

120.72

ug/l

1.26

(3004588) Protein electrophoresis panel - Serum or Plasma

265

2006

1.35

4.90

2.0

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

154

1062

1.47

4.87

1.7

1.4

1.45

1.08

g/l

0.80

144

958

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

556

4635

1.24

4.87

1.7

1.6

2.17

1.49

mg/l

2.80

475

3670

(3006462) Nitrate [Presence] in Urine

106

2.56

4.87

5.1

3.1

—

(4211845) Urine protein measurement

119

2.45

4.78

4.8

3.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

183

1311

1.42

4.73

2.5

—

(3045142) Bone marrow Pathology biopsy report

109

2.49

4.61

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

581

1.62

4.61

2.1

2.2

32.00

34.05

umol/l

0.30

510

(3022806) Fractional oxyhemoglobin in Capillary blood

313

1.83

4.48

1.9

89.20

89.04

0.06

308

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

550

1.62

4.37

1.8

1.5

—

(3045788) Cell count panel - Pleural fluid

302

1.83

4.33

1.3

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.89

4.32

2.9

2.1

0.82

1.32

0.80

(3033799) Differential panel - Peritoneal fluid

2.84

4.21

1.5

1.6

—

(3021960) Folate [Moles/volume] in Serum or Plasma

910

8056

1.18

4.18

1.9

1.8

19.33

19.31

nmol/l

0.01

787

6794

(3013727) Leukocytes other/Leukocytes in Blood

3.27

4.18

3.4

2.6

56.67

62.73

0.54

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

165

1192

1.40

4.11

1.9

1.4

3.83

3.80

g/l

0.07

148

1047

(40768793) Breast Pathology biopsy report

3.08

4.07

1.3

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

165

1197

1.40

4.02

1.9

1.4

4.03

4.15

g/l

1.37

149

1057

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

165

1198

1.40

4.00

1.9

1.4

7.62

7.46

g/l

0.61

148

1055

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

140

992

1.43

3.90

1.3

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

674

5847

1.19

3.89

1.8

1053.17

1131.92

nmol/l

1.48

508

4404

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

962

8598

1.17

3.88

2.2

2.3

200.26

259.22

u/l

2.11

919

8065

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

155

1121

1.40

3.85

1.9

1.4

3.12

2.90

g/l

1.81

139

979

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

141

1009

1.41

3.73

1.8

1.5

0.48

0.42

g/l

0.10

122

851

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

146

1052

1.41

3.72

1.9

1.4

10.15

10.39

g/l

0.26

128

905

(21494814) CD8 cells/Lymphocytes in Specimen

3.83

3.68

1.8

2.9

26.77

24.38

0.21

(40765096) Chromosome analysis panel by Banding

5.01

3.68

1.5

1.1

—

(3020891) Body temperature

192

1463

1.33

3.47

5.4

4.4

36.95

36.92

°c

0.56

187

1443

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

118

832

1.43

3.42

3.5

3.0

4.22

4.33

pmol/l

0.54

107

712

(3009445) Proteinase 3 Ab [Units/volume] in Serum

153

1129

1.37

3.41

1.7

1.5

21.53

25.01

iu/ml

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

365

1.65

3.39

1.5

1.8

2.53

20.64

iu/l

0.54

136

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.66

3.38

1.6

2.2

1342.71

36545.67

e6/l

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

572

1.52

3.35

1.6

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

345

1.66

3.29

1.9

2.1

1.60

1.45

g/24h

0.16

182

(21494434) Karyotype in Bone marrow

135

2.08

3.27

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

156

2.00

3.23

1.2

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.44

3.20

1.5

2.3

1803.70

503.00

e6/l

—

(3028271) Lactate [Moles/volume] in Capillary blood

410

1.60

3.20

2.0

1.9

1.64

1.77

mmol/l

0.63

399

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

675

5949

1.17

3.18

1.7

1.8

23868013.35

28783233.83

pmol/l

0.07

574

4798

(21494755) Public health laboratory ask at order entry panel

561

0.53

3.10

1.2

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

123

891

1.39

3.09

4.9

4.2

4.12

3.97

mmol/l

1.68

118

879

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

438

1.56

3.08

1.1

1.2

23.34

19.55

u/l

0.41

368

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

890

8026

1.15

3.07

3.1

0.77

ug/l

0.07

639

5720

(40762887) Creatinine [Moles/volume] in Blood

5.01

3.04

1.4

1.8

—

(1761868) Lipid panel - Serum or Plasma

532

6087

0.85

3.03

3.3

3.9

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

360

3015

1.22

3.02

4.6

5.6

32.55

33.29

0.58

233

1949

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

436

1.55

2.92

1.6

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

566

1.48

2.91

1.6

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2027

19326

1.13

2.83

5.1

4.7

2.02

2.09

mu/l

1.46

1835

17327

(3044927) Protein electrophoresis panel - Urine

360

1.59

2.83

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

299

1.65

2.79

3.8

—

(3014271) Vancomycin [Susceptibility]

194

1.81

2.79

2.8

3.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

108

781

1.39

2.78

1.8

1.5

0.00

g/l

-0.00

102

717

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

108

782

1.39

2.76

2.0

2.2

174.41

114.34

ug/min

0.49

445

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

107

776

1.39

2.71

1.2

118.40

97.33

u/ml

0.14

274

(3017446) Testosterone [Moles/volume] in Serum or Plasma

225

1815

1.26

2.69

1.9

2.2

10.40

15.27

nmol/l

14.15

193

1592

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

296

1.63

2.64

9.5

4.6

1114.27

490.76

iu/ml

0.26

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

112

823

1.37

2.64

1.8

1.4

0.00

g/l

-0.00

103

721

(44816559) Phosphatidylethanol [Mass/volume] in Blood

728

0.63

2.60

2.0

1.4

0.31

0.32

mg/l

0.04

313

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

385

1.54

2.58

1.7

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

192

1.78

2.57

1.3

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

200

1.76

2.55

1.7

1.4

13.46

14.36

u/l

0.45

191

(3026389) Candida sp identified in Specimen by Organism specific culture

215

1.73

2.55

1.5

1.4

—

(3037756) Immunofixation for Serum or Plasma

558

1.44

2.54

1.2

—

(3002619) Bacteria identified in Specimen by Culture

2.73

2.54

1.4

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

115

855

1.36

2.53

1.8

1.5

0.01

0.02

g/l

0.48

108

764

(3048879) Bone marrow aspiration report

2.60

2.52

1.1

1.0

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.50

2.52

1.1

1.2

3.50

10.38

pmol/l

—

(44790048) Parainfluenza type 2 nucleic acid detection

269

1.64

2.52

1.6

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

269

1.64

2.52

1.6

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

269

1.64

2.52

1.6

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

269

1.64

2.52

1.6

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

677

1.40

2.51

4.6

3.8

1.60

1.62

index

0.01

339

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

564

1.43

2.42

1.3

1.2

104.00

360.45

titre

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

506

1.45

2.41

1.7

1.3

—

(4281824) Cell count and differential, peritoneal fluid

2.17

2.40

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

204

1.72

2.40

1.3

1.2

—

(3035715) Granulocytes [#/volume] in Blood

321

1.57

2.37

2.9

3.0

5.03

4.77

e9/l

0.21

321

(3000494) Fungus identified in Specimen by Culture

295

2486

1.20

2.36

1.5

1.4

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

637

0.62

2.35

2.2

1.9

2.93

3.30

mmol/l

1.37

491

(3000570) Elastase.pancreatic [Mass/mass] in Stool

618

1.38

2.19

1.5

225.96

274.09

ug/g

1.38

391

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.69

2.15

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

175

1.72

2.08

2.1

2.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

329

3792

0.85

2.06

1.2

3.02

1.86

u/ml

0.32

945

(3051611) Lipemic interference index of Serum or Plasma

238

1.60

2.03

3.5

3.8

12.58

11.81

index

0.20

112

(3017704) Immunofixation for Urine

170

1.71

1.99

1.3

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.28

1.97

1.7

1.2

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

171

1.70

1.96

1.8

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

100

1297

0.76

1.94

1.2

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.73

1.93

1.0

1.4

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1732

16557

1.10

1.91

42.3

23.7

329.34

332.15

g/l

31.40

1717

16409

(3035947) Staphylolysin Ab [Units/volume] in Serum

113

1.86

1.91

1.1

—

3.57

iu/ml

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.24

1.90

1.7

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.24

1.90

1.7

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

106

1.89

1.90

1.4

1.5

6.60

8.08

u/l

0.19

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2.16

1.87

1.4

1.1

1.58

2.24

u/l

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

284

1.52

1.86

1.7

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

151

1.73

1.86

3.3

4.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

260

1.54

1.86

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

100

1.90

1.85

1.1

1.09

0.24

u/ml

0.38

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

222

0.45

1.82

1.5

1.3

1.40

1.49

g/l

—

222

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

4.17

1.82

1.0

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

4.17

1.82

1.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

4.17

1.82

1.0

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

387

1.43

1.76

1.1

1.2

—

0.95

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.33

1.74

3.3

1.9

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.29

1.70

2.4

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.88

1.70

1.0

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.88

1.70

1.0

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.91

1.69

1.5

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.91

1.69

1.5

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.91

1.69

1.5

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.91

1.69

1.5

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

179

1.62

1.69

1.5

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

179

1.62

1.69

1.5

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

179

1.62

1.69

1.5

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

292

1.48

1.66

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.58

1.65

1.1

2.2

3.75

4.71

ug/l

—

(3035933) Granulocytes/Leukocytes in Blood

367

1.42

1.65

3.1

2.9

62.21

60.48

0.38

367

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

589

1.33

1.65

1.5

1.6

11.79

10.68

iu/ml

0.03

136

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

310

1.46

1.63

1.7

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

255

1.49

1.57

1.3

1.8

353.24

286.44

mu/l

0.73

236

(3014891) Appearance of Pleural fluid

2.11

1.54

1.8

1.4

—

(3003181) Sodium [Moles/volume] in Urine

476

1.35

1.52

1.4

53.70

60.57

mmol/l

0.80

379

(4034850) Laboratory test

824

0.75

1.49

21.8

12.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

283

1.45

1.49

2.2

1.7

0.94

1.08

g/l

0.26

224

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

452

1.36

1.49

1.5

1.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.22

1.46

3.7

2.3

0.10

0.36

u/field

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

244

1.48

1.44

1.7

1.4

175.25

158.75

au/ml

0.51

(3044007) Cell count panel - Peritoneal fluid

1.97

1.43

1.6

1.8

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

212

1.51

1.42

1.3

0.20

0.21

nmol/l

0.24

182

(40768797) Stomach Pathology biopsy report

327

2912

1.14

1.38

1.2

—

(3025941) Bacteria identified in Stool by Culture

115

938

1.23

1.38

1.2

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.00

1.37

1.1

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1212

11526

1.08

1.37

4.6

4.2

21.33

24.77

13.59

635

5962

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

256

1.45

1.35

1.1

—

(3028433) Virus identified in Specimen by Culture

2.04

1.32

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2122

20641

1.08

1.30

5.9

6.29

6.21

mmol/l

1.74

1915

18458

(3026480) Teichoate Ab [Titer] in Serum

2.50

1.30

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.22

1.24

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

212

1.47

1.22

1.3

—

nmol/l

—

(3019832) Treponema pallidum Ab [Presence] in Serum

558

0.73

1.20

1.4

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

558

1.28

1.20

1.2

1.4

0.25

0.23

g/l

0.83

529

(3024263) Appearance of Synovial fluid

140

1.57

1.19

1.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1.75

1.18

1.0

1.1

0.33

1.24

u/ml

—

(3037522) Nuclear Ab [Titer] in Serum

286

2555

1.13

1.18

1.3

349.33

490.77

titre

1.80

599

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

181

1.49

1.17

1.1

245.17

181.75

miu/ml

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1601

15451

1.07

1.16

4.0

3.6

15.07

15.10

pmol/l

0.19

1429

13708

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

650

1.25

1.16

1.6

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

650

1.25

1.16

1.6

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

712

0.77

1.16

1.1

—

242.83

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

223

0.58

1.15

1.0

41.57

45.85

ng/l

—

135

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

223

0.58

1.15

1.0

359.43

337.42

ng/l

—

139

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

223

0.58

1.15

1.0

632.71

663.52

ng/l

—

135

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

272

3036

0.89

1.15

1.3

45.09

16.55

u/ml

0.70

1063

(3028717) Thiamine [Mass/volume] in Blood

2.50

1.15

1.0

1.2

77.60

61.20

ug/l

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

102

841

1.22

1.15

1.9

1.7

35.06

38.20

u/l

0.76

686

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

328

2965

1.12

2.3

2.5

5.13

7.43

ug/l

3.22

273

2553

(21494890) Protein electrophoresis panel - 24 hour Urine

267

1.39

1.12

1.7

1.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1.78

1.10

1.0

1.1

0.23

0.36

u/ml

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

243

1.40

1.09

1.3

1.2

240.14

279.75

u/ml

0.38

135

(3032057) Clostridioides difficile [Presence] in Stool

1.82

1.08

2.3

1.8

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.87

1.07

1.9

2.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.87

1.07

2.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.76

1.06

2.4

1.2

—

(3004775) Volume in Urine collected for unspecified duration

253

1.39

1.06

1.9

2.3

779.30

637.70

0.88

151

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

297

1.35

1.03

1.7

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.27

1.03

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.06

1.02

1.0

1.1

—

(3004451) EKG impression Narrative

179

1.45

1.02

1.6

1.3

—

(3008295) Osmolality of Serum or Plasma

230

1.39

1.01

1.2

1.4

280.79

274.37

mosm/kgh2o

0.63

155

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.62

0.99

1.1

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

378

1.30

0.99

1.5

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

774

1.21

0.99

1.5

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

2.17

0.98

2.2

1.7

—

(3000492) Spirometry study

188

1659

1.14

0.98

1.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

576

1.24

0.96

1.2

1.4

1.16

1.14

g/l

0.14

544

(3040151) Glucose [Moles/volume] in Capillary blood

389

1.29

0.96

4.2

26.0

7.93

7.80

mmol/l

0.08

315

(3051387) C reactive protein [Mass/volume] in Capillary blood

614

1.23

0.94

4.2

3.7

44.36

31.62

mg/l

1.52

465

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.89

0.94

1.0

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.89

0.94

1.4

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

322

1.31

0.90

1.3

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

538

1.23

0.88

1.3

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.79

0.87

4.1

2.1

0.60

0.61

mmol/l

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

128

1.49

0.85

1.2

1.0

2.32

3.14

u/ml

0.14

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2077

20332

1.06

0.84

7.6

7.8

41.75

41.28

mmol/mol

1.09

1898

18624

(3008401) Mugwort IgE Ab [Units/volume] in Serum

129

1.47

0.83

1.2

1.1

0.81

0.96

u/ml

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

138

1.45

0.81

1.6

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.55

0.81

1.5

1.2

40.96

38.52

g/l

0.74

(3000012) Reticulocyte production index

437

1.24

0.79

3.9

1.6

0.88

0.01

301

(3002079) Sodium [Moles/time] in 24 hour Urine

1.59

0.77

1.2

1.3

127.54

174.30

mmol/24h

1.79

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1.59

0.77

1.0

1.1

2.80

1.91

u/ml

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

0.00

0.77

0.0

1.2

—

41.40

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

520

1.21

0.77

1.2

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

140

1.43

0.76

2.7

2.0

145.85

130.26

ng/l

0.24

140

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

226

1.33

0.76

1.2

1.1

—

71.69

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.70

0.75

1.3

1.2

—

(1002224) Polysomnography panel

526

0.80

0.75

1.0

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

166

1.39

0.75

1.6

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

541

1.20

0.74

1.3

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

532

1.21

0.74

1.3

1.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

280

1.29

0.73

1.2

1.1

—

4.86

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.00

0.72

1.4

1.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1007

9698

1.05

0.72

2.3

77.38

78.29

nmol/l

0.43

894

8386

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

934

0.85

0.72

2.1

2.2

3.54

3.47

ratio

0.13

783

(40762365) Oxygen content in Arterial blood by calculation

1.67

0.68

3.9

2.6

12.50

15.04

ml/dl

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

474

1.21

0.67

1.2

1.4

—

(4062490) Immunoglobulin typing, IgG

170

1.35

0.67

1.3

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.63

0.66

12.1

13.3

5.73

5.12

mmol/l

—

(3012565) Volume of 24 hour Urine

1.49

0.66

1.6

2.1

2310.00

1876.76

—

(4015189) Microbial culture of sputum

1.51

0.65

1.5

2.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

145

1.38

0.65

1.6

1.3

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

197

1796

1.10

0.65

1.5

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

303

3249

0.92

0.65

1.3

37.26

41.09

iu/ml

0.21

106

947

(44786800) Granulocytes/Leukocytes in Body fluid

1.72

0.63

1.0

1.3

26.60

20.00

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

708

0.84

0.63

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

507

1.19

0.61

1.2

4.86

3.49

u/ml

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

325

1.23

0.60

1.3

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

508

1.18

0.60

1.2

3.80

10.74

u/ml

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.00

0.60

0.0

1.5

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.60

0.0

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

277

0.76

0.59

1.3

1.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.59

0.0

1.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

1.51

0.58

42.1

25.3

146.88

121.26

ug/l

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

1.71

0.57

3.3

1.2

16.85

57.90

u/l

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.71

0.57

1.2

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

796

0.86

0.57

1.1

—

2.12

—

(3024471) HLA-A [Type]

1.62

0.55

1.0

—

(3024932) HLA-DR beta [Type]

1.62

0.55

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

116

1.38

0.54

1.5

2.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.43

0.52

1.0

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

143

1.33

0.52

1.0

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

223

1.26

0.52

1.0

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

135

0.67

0.51

1.1

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

161

1.31

0.51

1.2

1.1

0.94

0.90

u/ml

0.02

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

1.41

0.51

1.9

1.2

33.21

28.38

umol/l

—

(3006270) Folate [Moles/volume] in Blood

251

1.24

0.50

1.2

305.36

323.92

nmol/l

0.18

187

(3009466) Valproate [Moles/volume] in Serum or Plasma

357

0.81

0.50

3.7

3.9

353.57

327.34

umol/l

0.51

299

(3004716) Salmonella sp identified in Stool by Organism specific culture

650

1.14

0.50

1.3

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

1059

0.89

0.49

1.3

485.17

275.67

u/ml

0.65

986

(3033099) Centromere Ab [Titer] in Serum

1.56

0.48

1.3

1.2

—

(3023419) Bacteria identified in Sputum by Culture

381

1.18

0.48

2.2

2.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

253

1.23

0.48

1.0

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

172

1.28

0.47

1.4

1.2

2.51

3.13

g/l

0.56

133

(3027135) IgG subclass 1 [Mass/volume] in Serum

172

1.28

0.47

1.4

1.2

5.79

7.36

g/l

1.20

131

(3024139) IgG subclass 3 [Mass/volume] in Serum

172

1.28

0.47

1.4

1.2

0.33

0.46

g/l

0.86

133

(3017569) Oxygen content in Arterial blood

208

1.25

0.47

1.7

1.8

14.91

16.20

1.33

208

(3003327) Ova and parasites identified in Stool by Light microscopy

504

0.85

0.46

1.4

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

192

1785

1.08

0.46

1.6

1.7

1.70

1.68

0.08

157

1457

(3004616) Nuclear Ab [Presence] in Serum

273

1.21

0.45

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

164

0.73

0.45

1.2

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

192

1.25

0.44

1.0

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

112

1.34

0.44

1.3

3.0

49.90

69.14

mg/l

—

(36660697) Celiac disease serology panel - Serum

121

1321

0.91

0.44

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2109

20817

1.04

0.42

5.7

6.5

2.36

2.39

mmol/l

0.64

1891

18974

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.64

0.42

1.2

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.64

0.42

1.2

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.64

0.42

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

0.64

0.42

1.2

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.64

0.42

1.2

1.0

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

322

1.18

0.42

1.8

1.4

67.19

65.36

0.12

215

(3018333) Ribosomal P Ab [Presence] in Serum

122

1.31

0.42

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

1.40

0.42

61.5

36.2

7.15

7.30

ug/l

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.38

0.41

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.41

0.0

1.1

—

6.31

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.1

—

2.06

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.41

0.0

1.2

—

(3019174) dRVVT (LA screen)

0.00

0.40

0.0

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.40

0.0

1.1

—

(4146454) Self-monitoring of blood glucose

324

1.17

0.40

2.1

2.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.36

0.39

1.3

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.31

0.39

1.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

446

1.14

0.39

1.3

1.4

—

11.32

—

(3011985) Renin [Units/volume] in Plasma

279

1.18

0.38

1.3

54.74

79.67

mu/l

0.54

247

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.39

0.38

1.4

1.5

48.60

49.19

umol/l

—

(40757373) Influenza virus identified in Isolate

1.34

0.38

3.0

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

495

1.13

0.37

1.4

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

809

0.90

0.37

3.1

3.2

0.79

0.82

nmol/l

0.38

657

(3010838) Calcium [Moles/time] in 24 hour Urine

290

1.17

0.36

1.9

1.8

3.88

4.41

mmol/24h

0.58

251

(3034426) Prothrombin time (PT)

1.43

0.35

1.2

1.3

24.83

28.74

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

162

1.23

0.35

2.0

2.1

47.80

246.52

ug/min

—

(3044941) Cell count panel - Synovial fluid

490

0.88

0.35

1.6

1.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

126

1.27

0.35

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

565

1.12

0.34

1.1

1.2

—

(3042733) HLA Ab [Presence] in Serum

1.36

0.34

4.3

4.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

990

9683

1.03

0.34

4.2

4.3

14.47

9.24

mg/mmol

3.01

735

6376

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

100

1.30

0.33

1.2

1.9

—

(3036670) Protein [Mass/volume] in Synovial fluid

109

1.28

0.33

1.3

1.1

30.39

38.78

g/l

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

118

1.27

0.33

1.3

1.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

425

1.13

0.33

1.7

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

176

0.79

0.32

1.4

1.6

—

1853.33

—

(3023420) DNA double strand Ab [Units/volume] in Serum

819

1.09

0.31

1.3

1.6

6.36

6.43

iu/ml

—

190

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

230

1.17

0.30

1.1

1.0

—

(3035880) pH of Pleural fluid

166

1.21

0.29

1.8

1.4

7.43

7.42

0.15

114

(3016879) Cocaine [Presence] in Urine

130

0.77

0.29

2.2

1.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

157

1.21

0.29

1.2

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.23

0.29

1.0

1.1

—

39.43

—

(3008898) HLA-B27 [Presence]

355

0.87

0.28

1.0

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

176

1.19

0.28

1.0

1.1

—

26.18

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

130

1.23

0.28

1.1

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

172

0.81

0.27

1.1

1.2

—

120.00

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

261

1.15

0.27

1.1

1.3

252.30

282.07

pmol/l

0.22

211

(3032773) Endomysium IgG Ab [Titer] in Serum

161

0.81

0.27

1.2

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

174

1652

1.06

0.27

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.68

0.26

7.4

8.8

7.28

5.27

kpa

—

(3023410) Appearance of Cerebral spinal fluid

178

1.18

0.26

2.0

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

127

0.79

0.25

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

118

1250

0.94

0.25

2.5

17.00

15.44

au/ml

—

(3047189) Immunofixation for 24 hour Urine

105

1.24

0.24

1.0

1.1

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

1.18

0.24

1.2

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

1.25

0.24

1.5

1.4

59.67

103.50

umol/l

—

(3007566) Smooth muscle Ab [Titer] in Serum

503

1.09

0.24

1.3

1.1

72.00

129.75

titre

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

106

1123

0.94

0.23

1.3

14.20

60.36

au/ml

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

746

1.07

0.23

1.4

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.28

0.23

1.0

1.1

—

(3016750) Collection duration of Urine

162

1.17

0.22

2.1

2.0

512.40

503.02

min

—

113

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.76

0.22

1.0

1.1

—

(3028300) Cannabinoids [Presence] in Urine

135

0.81

0.22

2.1

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.22

0.22

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

388

0.90

0.21

1.1

—

3.50

—

(4133840) Spirometry

1.19

0.21

1.0

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

212.00

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.21

0.0

1.3

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.21

0.0

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

135

1.19

0.21

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

135

1.19

0.21

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

1.22

0.21

1.0

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

134

0.82

0.20

1.3

1.4

168.14

156.60

pmol/l

0.12

134

(3027008) Opiates [Presence] in Urine

134

0.82

0.20

2.1

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

0.00

0.20

0.0

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

1.22

0.20

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

136

1.18

0.20

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

221

1.13

0.20

1.1

1.2

1.64

2.46

u/ml

0.91

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.21

0.19

3.1

2.2

9.67

9.84

kpa

0.09

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.21

0.19

3.1

2.2

4.47

5.04

kpa

1.56

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

146

1.16

0.19

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

961

9473

1.02

0.19

3.5

6.90

7.59

mmol/l

7.85

807

7874

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

1.22

0.19

1.0

1.2

—

48.00

—

(44806420) Estimation of glomerular filtration rate

165

1.15

0.19

2.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.13

0.18

2.0

1.3

7.98

9.92

ug/l

—

(3000764) Benzodiazepines [Presence] in Urine

132

0.83

0.18

2.1

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

121

0.83

0.18

1.0

—

(3048689) Calprotectin [Mass/mass] in Stool

189

1955

0.96

0.18

2.4

2.2

185.17

190.14

ug/g

0.06

151

1539

(3020650) Glucose [Presence] in Urine

1.17

0.17

1.7

1.6

0.00

0.10

estimate

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

285

2773

1.03

0.17

3.0

3.5

257.58

290.26

ng/l

0.64

261

2573

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.75

0.17

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

0.73

0.17

2.6

1.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

659

0.94

0.16

1.2

0.25

0.57

u/ml

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

148

1.15

0.16

1.1

1.3

118.53

92.67

pmol/l

1.24

148

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

162

0.86

0.16

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

158

1.14

0.16

1.1

2.23

2.24

mmol/l

0.01

144

(4268621) Lupus anticoagulant assay

158

1.14

0.16

2.1

2.2

—

(3016018) Differential panel - Cerebral spinal fluid

206

1.12

0.15

1.7

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1946

19327

1.02

0.15

4.3

4.7

1.35

1.25

mmol/l

8.24

1711

17312

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

245

1.10

0.15

1.3

1.4

—

192.81

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

140

1.14

0.15

1.1

—

(3027944) Amphetamines [Presence] in Urine

129

0.85

0.15

2.1

1.3

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.79

0.14

1.1

1.2

5.72

6.38

mmol/l

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.79

0.14

1.0

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

265

1.09

0.14

1.6

1.3

17114.65

306515.20

e6/l

4.51

189

(3007164) IgA [Mass/volume] in Serum or Plasma

327

3199

1.02

0.14

1.4

1.3

3.12

2.96

g/l

0.51

203

1786

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

112

1.16

0.14

1.2

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

208

1.11

0.13

1.6

1.4

—

(44813793) Dust mix specific IgE antibody measurement

110

0.82

0.13

1.2

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

442

1.06

0.12

1.3

1.7

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

219

0.91

0.11

1.1

1.2

—

62.13

—

(3006653) Thiamine [Moles/volume] in Blood

124

1.13

0.11

1.6

1.1

141.36

135.53

nmol/l

0.24

124

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

299

1.07

0.10

1.1

1.00

656.21

iu/ml

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

249

0.92

0.10

2.3

1.4

16.41

24.04

1.06

170

(3003740) Influenza virus B Ag [Presence] in Specimen

144

1.11

0.10

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

144

1.11

0.10

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

712

1.04

0.10

1.8

1.5

29846.09

16430.84

e6/l

0.82

506

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

1.09

0.09

1.0

1.2

18.00

10.72

mm/h

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

324

3193

1.02

0.08

12.4

8.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.78

0.08

1.0

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.09

0.08

1.3

1.21

1.17

mmol/l

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.03

0.07

1.3

1.2

—

(3012516) Albumin [Mass/volume] in Urine

948

9413

1.01

0.07

3.5

3.6

82.42

54.83

mg/l

3.91

735

6429

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

216

1.06

0.06

1.1

1.2

5.56

6.96

u/ml

—

108

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

100

0.90

0.06

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

111

0.90

0.06

2.0

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

647

0.97

0.05

1.5

23.15

29.57

u/ml

0.26

117

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

267

1.05

0.05

1.1

1.0

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

139

0.93

0.03

1.2

1.5

15.15

16.62

umol/l

0.22

125

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2033

20281

1.00

0.03

4.9

5.6

4.18

4.19

mmol/l

0.30

1825

18526

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

112

1.07

0.02

1.2

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

279

0.97

0.02

1.3

1.2

1.25

1.49

nmol/l

0.64

251

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

447

0.98

0.01

1.4

1.3

17.48

35.50

e6/l

0.49

345

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

453

1.01

0.01

1.5

1.4

1107.12

1049.46

e6/l

0.02

372

(3038177) Helicobacter pylori Ab [Presence] in Serum

219

1.00

0.00

1.1

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

208

1.01

0.00

1.6

1.7

8.91

8.10

mmol/l

0.59

208

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

151

0.99

0.00

1.1

1.5

—

(4195642) Thrombophilia screening test

187

1.02

0.00

1.1

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

112

0.98

0.00

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

112

0.98

0.00

1.1

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

176

1.02

0.00

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

612

1.00

0.00

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

123

0.97

0.00

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

185

1.03

0.00

1.0

1.1

—

1.54

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2009

20072

1.00

0.00

4.9

5.5

1.33

1.36

mmol/l

2.63

1795

18176

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

383

0.99

0.00

1.4

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

104

0.96

0.00

1.0

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

104

0.96

0.00

1.2

203.90

335.22

u/l

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

166

1.02

0.00

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

216

1.02

0.00

1.4

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

105

1.05

0.00

1.7

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.0

5.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

22.74

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.97

-0.00

1.0

—

(3007733) Chloride [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

98.80

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.4

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(40768446) Kidney Pathology biopsy report

0.87

-0.00

1.5

1.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.92

-0.00

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

0.99

-0.00

1.1

1.4

5.99

7.51

mmol/l

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

-0.00

0.0

1.8

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

5.20

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.99

-0.00

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.87

-0.00

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

0.92

-0.00

4.6

1.6

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

0.91

-0.00

1.9

1.3

82.05

64.50

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.8

—

2.68

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

2.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.99

-0.00

1.4

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

-0.00

0.0

1.5

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

0.96

-0.00

1.0

1.1

—

1.15

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

13.16

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

2.0

—

2.96

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.6

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_BLADDER – Malignant neoplasm of bladder

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of bladder

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of bladder (C3_BLADDER)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints